{"text_format":"2","workbook":"xls","n_sheets":3,"sheets":["Blad1","Blad2","Blad3"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Blad1","index":0,"n_rows":866,"n_cols":10,"rows_kept":866,"cut":false,"hidden":false,"merged":[[1,4,1,7]],"flags":["formulas_cached_only"]}
["Updated: 2 April 2015",{"$nulls":5}," "]
[{"$nulls":4},"Agreed text for productinformation-Overview "]
[]
[]
["Active Substance                                                   (green color = new in overview)                                              (orange color = changed in overview)","Topic  \nArt. 30 referral / Art. 31 referral / Paediatric WS art 45 / Paediatric WS art 46 / PSUR WS /  PRAC recommendation / Lareb Publication","Procedurenumber","Date of Decision","Hyperlink to the decision\n(Commission Decision, publication on CMD(h) website or EMA website, Board decisions on Lareb publication","Decision CMD(h)/PRAC  on implementation","Hyperlink to the Dutch translation of the productinformation (if applicable)","Notes on implementation (A=active; N=normal; C=combined, awaiting decision on other procedure)","Date start of implementation by MEB","Pharmaco-therapeutic group"]
[" 99mTc-albumin nanocolloid ","CSP"," HU/H/PSUR/0018/001","March 2011","http://db.cbg-meb.nl/veegactie/CSP/Tc-albuminNanocol-March2011.pdf",null,null,"N",null,"FT2"]
["113I- Meta-iodobenzylguanidine","CSP",null,"June 2010",null,null,null,"N",null,"FT2"]
["Abciximab","CSP","UK/H/PSUR/0019/001","September 2011",null,null,null,"N",null,"FT2"]
["Acamprosate ","CSP","IE/H/PSUR/0011/002","February 2012","http://db.cbg-meb.nl/veegactie/csp/acamprosate _Feb2012.pdf",null,null,"N",null,"FT1"]
["acarbose","CSP","ES/H/PSUR/0006/001","August 2010","http://db.cbg-meb.nl/veegactie/csp/Acarbose- Aug2010.pdf ",null,null,"N",null,"FT2"]
["acarbose","Paediatric WS art 45",null,"November 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Acarbose-Nov2011.pdf","N",null,"FT2"]
["acebutolol","CSP ","DK/H/PSUR/0026/001","December 2010","http://db.cbg-meb.nl/veegactie/csp/Acebutolol-december2010.pdf",null,null,"N",null,"FT2"]
["aceclofenac","CSP","HU/H/PSUR/0030/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/Aceclofenac-Oct2010.pdf",{"$nulls":4},"FT1"]
["Aceclofenac","CSP","HU/H/PSUR/0030/001","December 2011","http://db.cbg-meb.nl/veegactie/csp/Aceclofenac_Dec2011.pdf",null,null,"N",null,"FT1"]
["acetylsalicylzuur","PhVWP recommendation",null,"June 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/ASA-ibuprofen16-10-08.pdf","A","September 2009","FT1, FT2"]
["Aciclovir","CSP","DK/H/PSUR/0035/002","Juli 2013","http://db.cbg-meb.nl/veegactie/csp/Aciclovir_Jul2013.pdf",null,null,"N",null,"FT4"]
["Aciclovir","Paediatric WS art 45"," DK/W/011/pdWS/001","May 2011","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h20656.pdf","N",null,"FT4"]
["Acitretin","CSP","DK/H/PSUR/0024/001","December 2010","http://db.cbg-meb.nl/veegactie/csp/acitretin_December_2010.pdf",null,null,"N",null,"FT1"]
["adapalene","CSP","IE/H/PSUR/0001/002","May 2011","http://db.cbg-meb.nl/veegactie/csp/adapalene-May2011.pdf",null,null,"N",null,"FT1"]
["adenosine","CSP",null,"October 2010","http://db.cbg-meb.nl/veegactie/csp/Adenosine-Oct2010.pdf",null,null,"N",null,"FT2"]
["adenosine","Paediatric WS art 45","UK/H/0040/pdWS/001","July 2013",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/adenosine-July2103.pdf","N",null,"FT2"]
["alendronate","Paediatric WS art 45",null,"May 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/alendronaat-May2011.pdf","N",null,"FT2"]
["alendronate","PhVWP recommendation",null,"April 2009","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/Alendronic-acid-stress-fractures.pdf","A","October 2009","FT2"]
["alendronate","CSP"," UK/H/PSUR/0070/002","March 2012","http://db.cbg-meb.nl/veegactie/CSP/alendronate-March2012.pdf",null,null,"N",null,"FT2"]
["alendronate","PhVWP recommendation",null,"October 2010","CMD website","Implementation until May 2011","http://db.cbg-meb.nl/veegactie/nlvert/Alendronate-October2010.pdf","A","1 December 2010","FT2"]
["alendronic acid","Art 20/Art 30 referral ",null,"July 2011","CMD website and EU commission website",null,"CMD website and EU commission website","A","August 2011","FT2"]
["Alfentanil","Art 45","BE/W/0003/pdWS/001","February 2013","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Art45_Alfentanil_April2013.pdf","N",null,"FT1"]
["Alfuzosin","CSP","SE/H/PSUR/0033/002","4 maart 2014 ","http://db.cbg-meb.nl/veegactie/csp/Alfuzosin_oktober2014.pdf","HMA website",null,"N",null,"FT4"]
["Alfuzosine","CSP ",null,"October 2010","http://db.cbg-meb.nl/veegactie/csp/Alfuzosine-oct2010.pdf",null,null,"N",null,"FT4"]
["Alfuzosine","Paediatric WS art 46"," SE/W/012/pdWS/001","July 2011","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h103826.pdf","N",null,"FT4"]
["allopurinol","PhVWP recommendation",null,"October 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","N","February 2012","FT1"]
["Allopurinol","PhVWP recommendation",null,"July 2012","CMD website","2012-12-01","http://db.cbg-meb.nl/veegactie/nlvert/Allopurinol_Jul2012.pdf","A",null,"FT1"]
["Almotriptan","CSP","ES/H/PSUR/0008/002","February 2012","http://db.cbg-meb.nl/veegactie/csp/Almotriptan_Feb2012.pdf",null,null,"N",null,"FT1"]
["Alprazolam","Paediatric WS art 45"," UK/W/032/pdWS/001","January 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Alprazolam_January2012.pdf","N",null,"FT1"]
["Alprazolam","CSP"," FR/H/PSUR/0036/001","November 2011","http://db.cbg-meb.nl/veegactie/CSP/CSP_Alprazolam_16Nov2011.pdf",null,null,"N",null,"FT1"]
["alprostadil","CSP",null,"March 2010","http://db.cbg-meb.nl/veegactie/csp/Alprostadil-March-2010.pdf",null,null,"N",null,"FT2"]
["Alprostadil","CSP","UK/H/PSUR/0020/002","November 2011"," http://db.cbg-meb.nl/veegactie/csp/Alprostadil_Nov2011.pdf",null,null,"N",null,"FT4"]
["Alprostadil","CSP","UK/H/PSUR/0020/002","February 2012","http://db.cbg-meb.nl/veegactie/csp/alprostadil_erectile_dysfunction_Feb2012.pdf",null,null,"N",null,"FT2"]
["Amikacine","Paediatric WS art 45"," SE/W/003/pdWS/001","February 2011","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h22424.pdf","N",null,"FT4"]
["Aminolevulinic acid ","PSUSA","EMEA/H/C/2204/01","April 2014","EU Commission website",null,null,"N",null,"FT1"]
["amiodarone","Paediatric WS art 45",null,"February 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Amiodarone-Febr2011.pdf","N",null,"FT2"]
["amitriptyline","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["Amitriptyline","PhVWP recommendation ",null,"March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/TCAs-5-2010.pdf","A","June 2010","FT1"]
["amlodipine","CSP"," DK/H/PSUR/0007/002","October 2011","http://db.cbg-meb.nl/veegactie/CSP/Amlodipine-Oct2011.pdf",null,null,"N",null,"FT2"]
["amlodipine","Paediatric WS art 45",null,"October 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Amlodipine.pdf","A","September 2009","FT2"]
["amlodipine","Art 30 referral",null,"October 2011","EU commission website",null,"EU commission website","A","November 2011","FT2"]
["Amoxicilline","Paediatric WS art 45"," SE/W/009/pdWS/001","August 2010","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h17421.pdf","N",null,"FT4"]
["Amoxicilline/Clavulaanzuur","Art 30 referral",null,"October 2009","EU commission website",null,"EU commission website","A","January 2010","FT4"]
["Amsacrine","CSP","NL/H/PSUR/0011/001","January 2012","http://db.cbg-meb.nl/veegactie/csp/Amsacrine_Jan2012.pdf",null,null,"N",null,"FT3"]
["Anastrozole","CSP","UK/H/PSUR/0046/002","July 2013","http://db.cbg-meb.nl/veegactie/csp/Anastrozole_Jul2013.pdf",null,null,"N",null,"FT3"]
["Anti-psychotica","PhVWP recommendation ",null,null,"CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["Apomorphine","PhVWP recommendation ",null,"July 2012","CMD website","Nov 2012","http://db.cbg-meb.nl/veegactie/nlvert/Divers_PhVWP_risk_of_impils_control_disorders_Jul2012.pdf","A",null,"FT1"]
["Atenolol+Chloortalidon","CSP","SK/H/PSUR/0003/002","January 2013","http://db.cbg-meb.nl/veegactie/csp/atenolol+chloortalidon_Jan2013.pdf",null,null,"N",null,"FT2"]
["Atenolol+Nifedipine","CSP","DE/H/PSUR/0003/001","October 2011","http://db.cbg-meb.nl/veegactie/csp/Atenolol+Nifedipine_Oct2011.pdf",null,null,"N",null,"FT2"]
["atenolol-chlorothalidon","CSP",null,"December 2009","http://db.cbg-meb.nl/veegactie/csp/atenolol-chloortalidon-Dec2009.pdf",null,null,"N",null,"FT2"]
["atomoxetine","Art 31 referral",null,"August 2005","EU commission website",null,"EU commission website","A",null,"FT1"]
["atorvastatine","PhVWP recommendation",null,"October 2009","CMD website","Implementation until June 2010","http://db.cbg-meb.nl/veegactie/nlvert/statines-Oct2009.pdf","A","February 2010","FT2"]
["atorvastatine","Art 30 referral",null,"December 2010","EU commission website",null,"EU commission website","A","February 2011","FT2"]
["atorvastatine","Art 29 referral",null,"July 2010","CMD website",null,"CMD website","C (with Art 30)","February 2011","FT2"]
["atorvastatine","PhVWP recommendation ",null,"February 2012","CMD website","Implementation until May 2012","http://db.cbg-meb.nl/veegactie/nlvert/Statine-March2012.pdf","A","March 2012","FT2"]
["Atovaquaone","CSP",null,"October 2009","http://db.cbg-meb.nl/veegactie/csp/Atovaquone.pdf",null,null,"N",null,"FT4"]
["Atovaquone/Proguanil hydrochloride","CSP"," UK/H/PSUR/0022/001","February 2011","http://db.cbg-meb.nl/veegactie/csp/Atovaquone-feb_2011.pdf",null,null,"N",null,"FT4"]
["Atracurium","Art 45","IE/W/0008/pdWS/001","December 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Art45_Atracurium_sep2012.pdf","N",null,"FT1"]
["atracurium             ","CSP ","DE/H/PSUR/0029/001","November 2010","http://db.cbg-meb.nl/veegactie/csp/Atracurium-November2010.pdf",null,null,"N",null,"FT1"]
["Azithromycine","CSP",null,"June 2009","http://db.cbg-meb.nl/veegactie/csp/Azithromycin-June2009.pdf",null,null,"N",null,"FT4"]
["Azithromycine","CMD recommendation",null,"October 2010","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h29676.pdf","N",null,"FT4"]
["Azithromycine","CSP","FI/H/PSUR/0007/002","February 2013","http://db.cbg-meb.nl/veegactie/csp/Azithromycin_Feb2013.pdf",null,null,"N",null,"FT4"]
["Aztreonam","CSP","DK/H/PSUR/0019/001","December 2010","http://db.cbg-meb.nl/veegactie/csp/Aztreonam-dec2010.pdf",null,null,"N",null,"FT4"]
["Azytromicine","PRAC recommendation",null,"juli 2014","http://db.cbg-meb.nl/veegactie/csp/Azithromycine_jul2014.pdf",null,null,"N",null,"FT4"]
["Bambuterol","CSP",null,"October 2010","http://db.cbg-meb.nl/veegactie/csp/Bambuterol-Oct2010.pdf",null,null,"N",null,"FT3"]
["barnidipine","CSP"," NL/H/PSUR/0013/002","April 2011","http://db.cbg-meb.nl/veegactie/csp/barnidipine-April2012.pdf",null,null,"N",null,"FT2"]
["befunolol","PhVWP recommendation",null,"January 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Beta_blocking_agents_January2012.pdf","N",null,"FT1"]
["benazapril","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["benazapril","CSP",null,"October 2008","http://db.cbg-meb.nl/veegactie/csp/benazepril-2008.pdf",null,null,"N",null,"FT2"]
["benazapril-HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["Bendamustinhydrochlorid","PSUR WS","DE/H/1250/001/DC","December 2013","http://db.cbg-meb.nl/veegactie/csp/Bendamustinhydrochlorid_dec2013.pdf",null,null,"N",null,"FT3"]
["Betahistine","CSP"," LV/H/PSUR/0009/001","2012-08-01","http://db.cbg-meb.nl/veegactie/CSP/Betahistine_CSP_Aug2012.pdf",null,null,"N",null,"FT1"]
["betaxolol","PhVWP recommendation",null,"January 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Beta_blocking_agents_January2012.pdf","N",null,"FT1"]
["bezafibrate","Art 31 referral",null,"February 2011","EU commission website",null,"EU commission website","A","March 2011","FT2"]
["Bicalutamide","CSP","DK/H/PSUR/0006/002","September 2011","http://db.cbg-meb.nl/veegactie/csp/Bicalutamide_Sep2011.pdf",null,null,"N",null,"FT3"]
["Biperideen","PSUR WS","AT/H/PSUR/0039/001","4 August 2014","CMDh website ",null,null,"N",null,"FT1"]
["Bisacodyl","Paediatric WS art 45"," DK/W/002/pdWS/001","July 2010","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h03843.pdf","A","February 2011","FT4"]
["bisoprolol","CSP"," FI/H/PSUR/0002/002","December 2011","http://db.cbg-meb.nl/veegactie/CSP/Bisoprolol-December2011.pdf",null,null,"N",null,"FT2"]
["Botulinum Toxin A (different indications > 2 CSPs)","CSP","IE/H/PSUR/0015/006","2013-01-01","http://db.cbg-meb.nl/veegactie/csp/Botulinum_toxin_A_Oct2011.pdf",null,null,"N",null,"FT1"]
["Botulinum Toxin Type A-Hemagglutinin Complex","CSP","SE/H/PSUR/0048/003","November 2013","http://db.cbg-meb.nl/veegactie/csp/Botulinum_toxin_A_Nov2013.pdf",null,null,"N",null,"FT1"]
["brimonidine","CSP",null,"December 2009","http://db.cbg-meb.nl/veegactie/csp/brimonidine-12-2009.pdf",null,null,"N",null,"FT1"]
["bromocriptine","Art 31 referral",null,"January 2009","EU commission website",null,"EU commission website","A","January 2009","FT1"]
["Bromocriptine","PhVWP recommendation ",null,"July 2012","CMD website","Nov 2012","http://db.cbg-meb.nl/veegactie/nlvert/Divers_PhVWP_risk_of_impils_control_disorders_Jul2012.pdf","A",null,"FT1"]
["Bromperidol","CSP","NL/H/PSUR/0041/001","August 2011","http://db.cbg-meb.nl/veegactie/csp/bromperidol_Aug2011.pdf",null,null,"N",null,"FT1"]
["broomperidol/broomperidol decanoaat","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["brotizolam","CSP",null,"March 2009","http://db.cbg-meb.nl/veegactie/csp/brotizolam-3-2009.pdf",null,null,"N",null,"FT1"]
["Brotizolam","CSP","PT/H/PSUR/001/002","July 2011","http://db.cbg-meb.nl/veegactie/csp/Brotizolam_July2011.pdf",null,null,"N",null,"FT1"]
["Budesonide","Paediatric WS art 45",null,"September 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Budesonide.pdf","N",null,"FT3"]
["Budesonide","CSP"," DK/H/PSUR/0041/001","November 2011","http://db.cbg-meb.nl/veegactie/csp/Budesonide-nov2011.pdf",null,null,"N",null,"FT3"]
["Budesonide + formoterol","CSP",null,"July 2009","http://db.cbg-meb.nl/veegactie/csp/Budesonide-Formoterol.pdf",null,"http://db.cbg-meb.nl/veegactie/nlvert/Budesonide-formoterol.pdf","N",null,"FT3"]
["Budesonide/Formoterol","Paediatric WS art 45","DE/W/046/pdWS/001","December 2012","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Paediatric_Regulation/Assessment_Reports/Article_45_work-sharing/Budesonide_Formoterol_2013_01_Art.45_PAR.pdf",null,null,"N",null,"FT3"]
["Budesonide-Formoterol","CSP"," SE/H/PSUR/0012/003","May 2011","http://db.cbg-meb.nl/veegactie/csp/Budesonide-Formoterol-May2011.pdf",null,null,"N",null,"FT3"]
["buflomedil","CSP",null,"July 2009","http://db.cbg-meb.nl/veegactie/csp/Buflomedil-June2009.pdf",null,null,"N",null,"FT2"]
["Bupivacaine","Art 45","DE/W/042/pdWs/001","November 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Art45_Bupivacaine_Nov2012.pdf","N",null,"FT1"]
["bupropion","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["bupropion","CSP"," NL/H/PSUR/0020/005 ","November 2011","http://db.cbg-meb.nl/veegactie/CSP/bupropion-aid-to-smoking-cessation-csp-nov2011.pdf",null,null,"N",null,"FT1"]
["bupropion","CSP"," NL/H/PSUR/0020/005","November 2011","http://db.cbg-meb.nl/veegactie/CSP/Bupropion-major-depressive-episodes-Nov2011.pdf",null,null,"N",null,"FT1"]
["buserelin","PhVWP recommendation",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/GnRH-March2012.pdf","A","April 2012","FT2"]
["Buspirone HCL","CSP","AT/H/PSUR/0033/001","January 2012","http://db.cbg-meb.nl/veegactie/csp/buspirone_Jan2012.pdf",null,null,"N",null,"FT1"]
["Cabergoline","PhVWP recommendation",null,"July 2012","CMD website","Nov 2012","http://db.cbg-meb.nl/veegactie/nlvert/Divers_PhVWP_risk_of_impils_control_disorders_Jul2012.pdf","A",null,"FT1"]
["cabergoline","Art 31 referral",null,"January 2009","EU commission website",null,"http://db.cbg-meb.nl/veegactie/nlvert/cabergoline-pergolide-fibrose.pdf","A","January 2009","FT1, FT2"]
["cabergoline ","CSP","IT/H/PSUR/0012/003","July 2013","http://db.cbg-meb.nl/veegactie/csp/carbergolineJuly2013.pdf",{"$nulls":4},"FT1/FT2"]
["Calcipotriol/betametason (zalf)","Art 46","DK/W/0027/pdWS/001","March 2013","CDM webiste",null,"http://db.cbg-meb.nl/veegactie/nlvert/Art46_maart2013_Calcipotriol_betamethasone.pdf","N",null,"FT1"]
["Calcipotriol/betamethasone dipropionate","Paediatric WS art 46","DK/W/0027/pdWS/002","26 March 2014","CMDh website",null,"http://db.cbg-meb.nl/veegactie/nlvert/calcipotriol_betamethasone_dipropionate.pdf","N",null,"FT1"]
["Calcitonine","Paediatric WS art 45"," UK/W/001/pdWS/001","June 2009","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h08201.pdf","N",null,"FT4"]
["Calcitriol","CSP",null,"September 2009","http://db.cbg-meb.nl/veegactie/csp/Rocaltrol.pdf",null,null,"N",null,"FT4"]
["calciumcarbonate","WS art 45","UK/W/051/pdWS/001","Augustus 2014",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/calciumcarbonate_augustus2014.pdf","N",null,"FT4"]
["candesartan","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","A","November 2010","FT2"]
["candesartan","Art 30 referral",null,"July 2010","EU commission website",null,"EU commission website","A","November 2010","FT2"]
["candesartan","Paediatric WS art 46","UK/W/0023/pdWS/002","September 2013","CMD-website",null,null,"N",null,"FT2"]
["candesartan HCT","Art 30 referral",null,"September 2010","EU commission website",null,"EU commission website","A","November 2010","FT2"]
["candesartan-HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","A",null,"FT2"]
["capsicum ointment","CSP",null,"September 2010","http://db.cbg-meb.nl/veegactie/csp/CapsicamOintment-Sep2010.pdf",{"$nulls":4},"FT1"]
["captopril-HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["captopril-HCT","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-zwangerschap-lactatie.pdf","C, awaiting PhVWP decision on HCT and lactation",null,"FT2"]
["Carbamazepine","PhVWP recommendation",null,"July 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/carbamazepine-related-stevens-2008.pdf","A","July 2008","FT1"]
["Carbamazepine","PhVWP recommendation",null,"July 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/anti-epileptics-and-suicidal-behaviour-lamotrigine-2008.pdf","A"]
["Carbamazepine","PhVWP recommendation",null,"February 2012","CMD website","2012-04-01","http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","C","February 2012","FT1"]
["carbamazepine","PhVWP recommendation",null,"October 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","C","February 2012","FT1"]
["Carbamazepine","PhVWP recommendation",null,"July 2012","CMD website","2012-11-01","http://db.cbg-meb.nl/veegactie/nlvert/Carbamazepine_Jul2012.pdf","A",null,"FT1"]
["Carbomer","Paediatric WS art 45","AT/W/0011/pdWS/001","July 2012",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/Art45_Carbomer_Jul2012.pdf","N",null,"FT1"]
["carboplatin","Paediatric WS art 45",null,"February 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Carboplatine.pdf","N",null,"FT3"]
["carboplatin","CSP"," FR/H/PSUR/0034/001","November 2011","http://db.cbg-meb.nl/veegactie/csp/Carboplatin-Nov2011.pdf",null,null,"N",null,"FT3"]
["carteolol","PhVWP recommendation",null,"January 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Beta_blocking_agents_January2012.pdf","N",null,"FT1"]
["Carteolol","CSP","SK/H/PSUR/0002/002","March 2012","http://db.cbg-meb.nl/veegactie/csp/Carteolol_Mar2012.pdf",null,null,"N",null,"FT2"]
["Carvedilol","CSP","FI/H/PSUR/0017/002","June 2013","http://db.cbg-meb.nl/veegactie/csp/Carvedilol_Jun2013.pdf",null,null,"N",null,"FT2"]
["cefepime","PSUR WS","PT/H/PSUR/0008/001","Mei 2014",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/Cefepime_mei2014.pdf","N",null,"FT4"]
["Cefepime","klinisch indicatie",null,"november 2015","http://db.cbg-meb.nl/veegactie/csp/Cefepime_november2014.pdf",null,null,null,"november 2015","FT4"]
["Cefotaxime","CSP ","AT/H/PSUR/0022/001","September 2010","http://db.cbg-meb.nl/veegactie/csp/Cefotaxime-aug2010.pdf",null,null,"N",null,"FT4"]
["Cefotaxime","CSP","AT/H/PSUR/0022/002","October 2013","http://db.cbg-meb.nl/veegactie/csp/Cefotaxime_Okt2013.pdf",null,null,"N",null,"FT4"]
["Ceftazidime","Art 30 referral",null,"January 2011","EU commission website",null,null,"A","January 2012","FT4"]
["Ceftazidime","CSP","DK/H/PSUR/0023/002","30 januari 2015","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/Ceftazidime_2015_01.pdf",null,null,"N"]
["Ceftriaxon","CSP",null,"October 2009","http://db.cbg-meb.nl/veegactie/csp/Ceftriaxon.pdf",null,null,"N",null,"FT4"]
["Ceftriaxon","Art. 30 referral","EMEA/H/A-30/1302","2014-03-01","EU commission website",null,"EU commission website","N",null,"FT4"]
["Ceftriaxon ","PhVWP recommendation ",null,"September 2009","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h09911.pdf","A","October 2009","FT4"]
["Cefuroxime axetil","Art 30 referral","EMEA/H/A-30/1157","August 2012","CMD website",null,null,"N",null,"FT4"]
["Cefuroxime axetil","CSP","EE/H/PSUR/0003/002","March 2013","http://db.cbg-meb.nl/veegactie/csp/Cefuroxime axetil_Mar2013.pdf",null,null,"N",null,"FT4"]
["Cefuroxime sodium","Art 30 referral","EMEA/H/A-30/1158","September 2012","CMD website",null,null,"N",null,"FT4"]
["Cefuroxime sodium","CSP","EE/H/PSUR/0004/002","March 2013","http://db.cbg-meb.nl/veegactie/csp/Cefuroxime sodum_Mar2013.pdf",null,null,"N",null,"FT4"]
["celecoxib","CSP",null,"November 2009","http://db.cbg-meb.nl/veegactie/csp/celecoxib-11-2009.pdf",null,null,"N",null,"FT1"]
["Cetirizine","CSP","FI/H/PSUR/0019/002","December 2013","http://db.cbg-meb.nl/veegactie/csp/Cetirizine_Dec2013.pdf",null,null,"N",null,"FT3"]
["chloorprothixeenhydrochloride","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["chloroquine","PRAC Signal",null,"Sept 2013","EMA website","60 days",null,"A","Oct 2013","FT4"]
["chlorprothixene ","CSP ","LV/H/PSUR/0003/001","December 2010","http://db.cbg-meb.nl/veegactie/csp/Chlorprothixene-December2010.pdf",null,null,"N",null,"FT1"]
["Ciclesonide","CSP"," UK/H/PSUR/0024/004","January 2011","http://db.cbg-meb.nl/veegactie/csp/Ciclesonide-Jan2011.pdf",null,null,"N",null,"FT3"]
["Ciclosporine","CSP"," EE/H/PSUR/0007/001","February 2011","http://db.cbg-meb.nl/veegactie/CSP/Ciclosporine-Febr2011.pdf",null,null,"N",null,"FT3"]
["Ciclosporine","CSP","EE/H/PSUR/0007/001","February 2011","http://db.cbg-meb.nl/veegactie/csp/Ciclosporine-Febr2011.pdf",null,null,"N",null,"FT3"]
["Ciclosporine (Sandimmun)","Art. 30 referral","EMEA/H/A-30/1320","October 2013","EMA website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Ciclosporine_Oct2013.pdf","N",null,"FT3"]
["cilazapril","Art 30 referral",null,null,"EU commission website",null,"EU commission website","A","November 2010","FT2"]
["cilazapril-HCT","Art 30 referral",null,"January 2011","EU commission website",null,"EU commission website","A",null,"FT2"]
["Ciloxan (ciprofloxacine)","Paediatric WS art 45",null,"August 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Ciloxan-Aug2008.pdf","N",null,"FT4"]
["ciprofibraat","CSP",null,"June 2010","http://db.cbg-meb.nl/veegactie/csp/Ciprofibrate-June2010.pdf",null,null,"N",null,"FT2"]
["ciprofibrate","Art 31 referral",null,"February 2011","EU commission website",null,"EU commission website","A","March 2011","FT2"]
["Ciproflaxacine","CSP"," NO/H/PSUR/0010","April 2011","http://db.cbg-meb.nl/veegactie/csp/Ciprofloxacine-apr2011.pdf",null,null,"N",null,"FT4"]
["Ciprofloxacin Hydrochloride/ dexamethasone acetate","CSP","DE/H/PSUR/0047/001","3 april 2013","http://db.cbg-meb.nl/veegactie/csp/Ciprofloxacinhydrochloride,dexamethasoneacetate_april2014.pdf","HMA website",null,"N",null,"FT4"]
["Ciprofloxacine","Art 30 referral",null,"October 2008","EU commission website",null,"EU commission website","A","December 2008","FT4"]
["Cisapride ","CSP","PT/H/PSUR/002/003","May 2011","http://db.cbg-meb.nl/veegactie/csp/cisapride_may_2011.pdf",null,null,"N",null,"FT4"]
["Cisatracurium ","CSP","UK/H/PSUR/0023/002 ","January 2011","http://db.cbg-meb.nl/veegactie/csp/CISATRACURIUM_Jan2011.pdf",null,null,"N",null,"FT1"]
["Cisplatin","CSP ",null,"January 2011","http://db.cbg-meb.nl/veegactie/csp/CISPLATIN-January2011.pdf",null,null,"N",null,"FT3"]
["citalopram","PhVWP recommendation ",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["citalopram","Art 31 referral",null,"August 2005","EU commission website",null,"EU commission website","A",null,"FT1"]
["Citalopram","PhVWP recommendation ",null,"March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/SSRIs-muv-Fluoxetine-5-2010.pdf","A","June 2010","FT1"]
["Citalopram","PhVWP recommendation ",null,"October 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Citalopram_brief-aan-registratiehouders.pdf","A",null,"FT1"]
["Citalopram","PhVWP recommendation ",null,"March 2012","CMD website","August 2012","http://db.cbg-meb.nl/veegactie/nlvert/SSRIs_increased_ risk_ of_male_infertilityMar2012.pdf","A",null,"FT1"]
["Citalopram","CSP","SE/H/PSUR/0015/002","2012-12-01","http://db.cbg-meb.nl/veegactie/csp/Citalopram_Dec2012.pdf",null,null,"N",null,"FT1"]
["Cladibrine","CSP","NL/H/PSUR/0025/002","March 2013","http://db.cbg-meb.nl/veegactie/csp/Cladibrine_Mar2013.pdf",{"$nulls":4},"FT3"]
["Clarithromycine","CSP ","IE/H/PSUR/0020/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/Clarithromycine-Oct2010.pdf",null,null,"N",null,"FT4"]
["Clarithromycine","Paediatric WS art 45","SK/W/0001/pdWS/001","November 2010","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h15868.pdf","N",null,"FT4"]
["Claritomycine",null,"IE/H/PSUR/0020/002","September 2013","http://db.cbg-meb.nl/veegactie/csp/Clarithromycine_Sep2013.pdf",null,null,"N",null,"FT4"]
["Clindamycin","PRAC recommendation",null,"April 2014","http://db.cbg-meb.nl/veegactie/csp/Clindamycin_april2014.pdf",null,null,"N",null,"FT4"]
["Clindamycine","CSP","AT/H/PSUR/0035/001","November 2013","http://db.cbg-meb.nl/veegactie/csp/Clindamycin_Nov2013.pdf",null,null,"N",null,"FT4"]
["Clindamycine","PRAC recommendation","EMA/PRAC/229812/2014","2014-04-25","EMA website",null,"http://db.cbg-meb.nl/veegactie/nlvert/PRAC_Clindamycine_april2014.pdf","N",null,"FT4"]
["clobazam","Paediatric WS art 45",null,"December 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Clobazam-Dec2010.pdf",null,null,"FT1"]
["clodronate","CSP","BE/H/PSUR/0011/001","October 2011","http://db.cbg-meb.nl/veegactie/CSP/ClodronateOctober2011.pdf",null,null,"N",null,"FT2"]
["clodronic acid","Art 30 referral",null,"July 2011","EU commission website",null,"EU commission website","A","August 2011","FT2"]
["clomipramine","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["Clomipramine","PhVWP recommendation ",null,"March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/TCAs-5-2010.pdf","A","June 2010","FT1"]
["clonazepam","CSP"," EE/H/PSUR/0009/001","July 2011","http://db.cbg-meb.nl/veegactie/CSP/clonazepam_CSP_July2011.pdf",null,null,"N",null,"FT1"]
["clonidine hydrochloride","Paediatric WS art 45"," NL/H/0017/pdWS/001","March 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/clonidine-hydrochloride-March2011.pdf","N",null,"FT1"]
["clopidogrel","Update safety information innovator",null,"January 2010","CMD website",null,null,"A",null,"FT2"]
["clopidogrel","PRAC Signal",null,"March 2013","EMA website","60 days",null,"A","Oct 2013","FT2"]
["clopidogrel","PRAC Signal",null,"Jan 2013","EMA website","60 days",null,"A","Oct 2013","FT2"]
["Clotiazepam","CSP","BE/H/PSUR/0002/002","June 2011","http://db.cbg-meb.nl/veegactie/CSP/CSP_clotiazepam_June2011.pdf",null,null,"N",null,"FT1"]
["clozapine","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["clozapine","Art 30 referral",null,"November 2002","EU commission website",null,"EU commission website","N",null,"FT1"]
["clozapine","PhVWP recommendation",null,"July 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antipsychotica_brief_registratiehouders.pdf","A",null,"FT1"]
["Colchicine","Paediatric WS art 45","UK/W/015/pdWS/001 ","Feb 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Colchicine_Feb2012.pdf","N",null,"FT1"]
["Colecalciferol","Artikel 45",null,"november 2014","http://db.cbg-meb.nl/veegactie/csp/Colecalciferol_mei2014.pdf",null,null,null,"november 2014","FT4"]
["Colecalciferol ","Paediatric WS art 45","UK/W/041/pdWS/001","6 May 2014","CMDh-website",null,null,"N",null,"FT4"]
["Colecalciferol and sodium fluoride","Paediatric WS art 45","UK/W/046/pdWS/001","26 September 2013","CMDh-website",null,null,"N",null,"FT4"]
["Core SPC for Trivalent Influenza Vaccines","core SmPC and PL",null,"December 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Core-SmPC-vaccins-Dec2011.pdf","N",null,"FT4"]
["corticorelin (human) trifuoroacteaat","CSP",null,"June 2009","http://db.cbg-meb.nl/veegactie/csp/Corticorelin-June2009.pdf",null,null,"N",null,"FT2"]
["Corticosteroids (inhaled and intranasal)","PhVWP recommendation",null,"November 2011","http://db.cbg-meb.nl/veegactie/csp/Corticosteroids-Nov2010.pdf",null,null,"A",null,"FT3"]
["cyperoteronacetaat","PhVWP recommendation",null,"November 2009","CMD website","Submission of variation 1 March 2010; approval of variation 1 May 2010","http://db.cbg-meb.nl/veegactie/nlvert/Cyproterone.pdf","A","February 2010","FT2"]
["dalteparine","CSP",null,"February 2010","http://db.cbg-meb.nl/veegactie/csp/Dalteparine.pdf",null,null,"N",null,"FT2"]
["danaparoid","CSP",null,"July 2008","http://db.cbg-meb.nl/veegactie/csp/danaproid-2008.pdf",null,null,"N",null,"FT2"]
["Daunorubicin /Daunoblastin","CSP",null,"May 2010","http://db.cbg-meb.nl/veegactie/csp/Daunorubicin-23022010.pdf",null,null,"N",null,"FT3"]
["desogestrel","CSP"," SE/H/PSUR/0001/002","May 2011","http://db.cbg-meb.nl/veegactie/csp/Desogestrel-May2011.pdf",null,null,"N",null,"FT2"]
["desogestrel","Paediatric WS art 45",null,"January 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/desogestrelJanuary 2012.pdf","N",null,"FT2"]
["desogestrel + ethinylestradiol","CSP"," FI/H/PSUR/0025/002","September 2011","http://db.cbg-meb.nl/veegactie/CSP/EE+Desogestrel-September2011.pdf",null,null,"N",null,"FT2"]
["desogestrel+ethinylestradiol","Paediatric WS art 45",null,"January 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/desogestrel+EE-January2012.pdf","N",null,"FT2"]
["Dexamethason","Paediatric WS art 45","MT/W/005/pdWS/001","Oktober 2012","http://db.cbg-meb.nl/veegactie/csp/Dexamethason-Oktober2012.pdf",null,null,"N",null,"FT4"]
["Dexamethasone combinaties","Paedatric WS art 45","MT/W/0006/pdWS/001","March 2013","CMD website","x","http://db.cbg-meb.nl/veegactie/nlvert/Dexamethasone_combinations_Mar2013.pdf","N",null,"FT4"]
["Dexibuprofen","CSP ","AT/H/PSUR/0009/002","February 2012","http://db.cbg-meb.nl/veegactie/csp/dexibuprofen_Feb2012.pdf",null,null,"N",null,"FT1"]
["Dexlansoprazol","Class effects of proton-pump inhibitors on magnesium blood levels in long-term users",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/PPI_hypomagnesiemie_maart2012.pdf","A","April 2012","FT4"]
["diclofenac","Paediatric WS art 45",null,"September 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Diclofenac-Sep2010.pdf",null,null,"FT1"]
["diclofenac (cutaneous formulations)","CSP"," DK/H/PSUR/0022/001","2011-11-01","http://db.cbg-meb.nl/veegactie/CSP/diclofenac-cutaneous-Nov2011.pdf",null,null,"N",null,"FT1"]
["diclofenac         ","CSP ","DK/H/PSUR/0022/001","December 2010","http://db.cbg-meb.nl/veegactie/csp/diclofenac-systemic-December2010.pdf",null,null,"N",null,"FT1"]
["Didanosine","CSP ","FR/H/PSUR/0030/001","September 2010","http://db.cbg-meb.nl/veegactie/csp/Didanosine-sep2010.pdf",null,null,"N",null,"FT4"]
["dienogest-EE","CSP"," NL/H/PSUR/0001/001","April 2011","http://db.cbg-meb.nl/veegactie/csp/dienogest-EE-April2011.pdf",null,null,"N",null,"FT2"]
["dihydroregocryptine","Art 31 referral",null,"January 2009","EU commission website",null,"EU commission website","A","January 2009","FT1"]
["diltiazem","CSP",null,"May 2010","http://db.cbg-meb.nl/veegactie/csp/Diltiazem-May2010.pdf",null,null,"N",null,"FT2"]
["Domperidon","CSP",null,"October 2009","http://db.cbg-meb.nl/veegactie/csp/DOMPERIDONE.pdf",null,null,"N",null,"FT4"]
["Domperidon","PhVWP recommendation",null,"November 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Domperideon-Nov2011.pdf","A","February 2012","FT4"]
["Domperidon","Art. 30 referral","EMEA/H/A-31/1365","Jul2014","EC website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Art30_domperidon_July2014.pdf","N",null,"FT4"]
["Domperidon","PSUR WS","BE/H/PSUR/0005/002","december 2014","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/domperidone.pdf",null,null,"N","december 2014","FT4"]
["Donepezil","PhVWP Risk of neuroleptic malignant syndrome (but insufficient evidence on causal relationship with serotonin syndrome)",null,"July 2012","-",null,"http://db.cbg-meb.nl/veegactie/nlvert/PHVWP_Donepezil_July2012.pdf","N",null,"FT1"]
["dosulepine","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["Dosulepine","PhVWP recommendation",null,"March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/TCAs-5-2010.pdf","A","June 2010","FT1"]
["doxazosine","PhVWP recommendation",null,"March 2009","CMD website","Submission of variation 15 June 2009; approval of variation 15 October 2009","http://db.cbg-meb.nl/veegactie/nlvert/doxazosin2008.pdf","A","March 2009","FT2"]
["doxazosine","CSP",null,"November 2008","http://db.cbg-meb.nl/veegactie/csp/doxazosin.pdf",null,null,"A","March 2009","FT2"]
["doxazosine","CSP"," DK/H/PSUR/0004/002","December 2011","http://db.cbg-meb.nl/veegactie/CSP/doxazosinDec2011.pdf",null,null,"N",null,"FT2"]
["doxepin","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["Doxepine","PhVWP recommendation",null,"March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/TCAs-5-2010.pdf","A","June 2010","FT1"]
["drosperinone + EE","CSP"," NL/H/PSUR/0022/003","August 2012","http://db.cbg-meb.nl/veegactie/CSP/estradiol-drospirenone-August2012.pdf",null,null,"N",null,"FT2"]
["Duact","CSP ","DK/H/PSUR/0027/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/Duact-Oct2010.pdf",null,null,"N",null,"FT3"]
["Dutasteride","CSP ",null,"July 2010","http://db.cbg-meb.nl/veegactie/csp/Dutasterid-jul2010.pdf",null,null,"N",null,"FT4"]
["Dutasteride","PSUR WS","SE/H/PSUR/0034/002","Juni 2014","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/dutasteride_SAR_2014_06.pdf","http://db.cbg-meb.nl/veegactie/csp/Dutasteride_juni_2014.pdf",null,"N","december 2014","FT4"]
["Ebastine","CSP","DK/H/PSUR/0043/001","June 2011","http://db.cbg-meb.nl/veegactie/csp/Ebastine_Jun2011.pdf",null,null,"N",null,"FT3"]
["ebastine","PSUR WS","DK/H/PSUR/0043/002","October 2014","http://db.cbg-meb.nl/veegactie/csp/",null,null,"N",null,"FT3"]
["Econazole","CSP ",null,"September 2010","http://db.cbg-meb.nl/veegactie/csp/Econazole-sep2010.pdf",null,null,"N",null,"FT4"]
["Econazole","PSUR WS","HU/H/PSUR/0016/002","2013","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/Econazole-econazole_combinations_SAR_2013_11.pdf","http://db.cbg-meb.nl/veegactie/csp/Econazole_november_2013.pdf",null,"N",null,"FT4"]
["Eletriptan","CSP"," CZ/H/PSUR/003/002","2012-11-01","http://db.cbg-meb.nl/veegactie/csp/Eletriptan_Nov2012.pdf",null,null,"N",null,"FT1"]
["enalapril","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["enalapril","CSP","SE/H/PSUR/0037/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/enalapril-Oct2010 .pdf",null,null,"N",null,"FT2"]
["enalapril HCT","PhVWP recommendation","SE/H/PSUR/0037/001","July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["enalapril-HCTZ","CSP","DK/H/PSUR/0036/001","August 2010"," http://db.cbg-meb.nl/veegactie/CSP/enalapril-HCTZ-August2010.pdf",null,null,"N",null,"FT2"]
["Entacapone","PhVWP recommendation",null,"July 2012","CMD website","Nov 2012","http://db.cbg-meb.nl/veegactie/nlvert/Divers_PhVWP_risk_of_impils_control_disorders_Jul2012.pdf","A",null,"FT1"]
["epinastine","CSP","SE/H/PSUR/0042/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/epinastine-Oct2010.pdf",{"$nulls":4},"FT1"]
["Epirubicin","CSP"," DK/H/PSUR/0016/002","may-12","http://db.cbg-meb.nl/veegactie/csp/Epirubicin_May2012.pdf",null,null,"N",null,"FT3"]
["Epirubicine","CSP",null,"July 2009","http://db.cbg-meb.nl/veegactie/csp/Epirubicin.pdf",null,"http://db.cbg-meb.nl/veegactie/nlvert/Epirubicine.pdf","N",null,"FT3"]
["eplerenone","CSP","NL/H/PSUR/0028/002","November 2012","http://db.cbg-meb.nl/veegactie/csp/http://db.cbg-meb.nl/veegactie/csp/eplerenone-November2012.pdf",null,null,"N",null,"FT2"]
["epoprostenol","CSP","IE/H/PSUR/0018/002","November 2012","http://db.cbg-meb.nl/veegactie/csp/epoprostenol-Nov2012.pdf",null,null,"N",null,"FT2"]
["eprosartan","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["eprosartan","CSP ","DE/H/PSUR/0033/001","December 2010","http://db.cbg-meb.nl/veegactie/csp/eprosartan-dec2010.pdf",null,null,"N",null,"FT2"]
["eprosartan-HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["escitalopram","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["escitalopram","Art 31 referral",null,"August 2005","EU commission website",null,"EU commission website","A",null,"FT1"]
["escitalopram","CSP",null,"December 2009","http://db.cbg-meb.nl/veegactie/csp/escitalopram-12-2009.pdf",null,null,"N",null,"FT1"]
["Escitalopram","PhVWP recommendation",null,"March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/SSRIs-muv-Fluoxetine-5-2010.pdf","A","June 2010","FT1"]
["Escitalopram","PhVWP recommendation ",null,"March 2012","CMD website","August 2012","http://db.cbg-meb.nl/veegactie/nlvert/SSRIs_increased_risk_of_male_infertilityMar2012.pdf","A",null,"FT1"]
["Escitalopram","CSP","SE/H/PSUR/0016/002","December 2012","http://db.cbg-meb.nl/veegactie/csp/Escitalopram_DEC2012.pdf",null,null,"N",null,"FT1"]
["escitalopram","PhVWP recommendation",null,"December 2011",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/Escitalopram_Dec2012.pdf","NA",null,"FT1"]
["esketamine","CSP",null,"May 2009","http://db.cbg-meb.nl/veegactie/csp/esketamine-5-2009.pdf",null,null,"N",null,"FT1"]
["esmolol","Paediatric WS art 45",null,"July 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/esmolol-juli2008.pdf","A","February 2009","FT2"]
["Esomeprazol","Others",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/PPI_botfractuur_maart2012.pdf","A","April 2012","FT4"]
["Esomeprazol","Others",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/PPI_hypomagnesiemie_maart2012.pdf","A","April 2012","FT4"]
["Esomeprazol/naproxen","Others",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/PPI_botfractuur_maart2012.pdf","A","April 2012","FT4"]
["estradiol","CSP"," UK/H/PSUR/0039/001","May 2011","http://db.cbg-meb.nl/veegactie/csp/estradiol-May2011.pdf",null,null,"N",null,"FT2"]
["Estradiol","CSP","UK/H/PSUR/0072/001","November 2012","http://db.cbg-meb.nl/veegactie/csp/Estradiol_Nov2012.zip",null,null,"N",null,"FT2"]
["etenogestel + EE","CSP",null,"April 2010","http://db.cbg-meb.nl/veegactie/csp/etonogestrelEE-april2010.pdf",null,null,"N",null,"FT2"]
["ethinylestradiol/levonorgestrel","CSP"," DK/H/PSUR/0054/001","April 2011","http://db.cbg-meb.nl/veegactie/CSP/EE-levonorgestrel-April2011.pdf",null,null,"N",null,"FT2"]
["etidronate","CSP","SE/H/PSUR/0031/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/Etidronate-Oct2010.pdf",null,null,"N",null,"FT2"]
["etidronic acid","Art 30 referral",null,"July 2011","EU commission website",null,"EU commission website","A","August 2011","FT2"]
["Etomidate","CSP","DE/H/PSUR/0025/001","July 2012","http://db.cbg-meb.nl/veegactie/CSP/Etomidate_CSP_July2012.pdf",null,null,"N",null,"FT1"]
["Etoposide","CSP","DK/H/PSUR/0029/001","Juni 2012","http://db.cbg-meb.nl/veegactie/csp/Etopside_Jun2012.pdf",null,null,"N",null,"FT3"]
["etoricoxib","CSP",null,"March 2010","http://db.cbg-meb.nl/veegactie/csp/etoricoxib-3-2010.pdf",null,null,"N",null,"FT1"]
["Exemestaan","CSP","UK/H/PSUR/0006/001","May 2013","http://db.cbg-meb.nl/veegactie/csp/Exemestane_mei2013.pdf",null,null,"N",null,"FT3"]
["Famciclovir","Art 30 referral",null,"2010-07-01","EU commission website",{"$nulls":4},"FT4"]
["Famciclovir ","Paediatric WS art 45"," DE/W/008/pdWS/001","October 2010","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h34066.pdf","N",null,"FT4"]
["Famciclovir ","CSP"," UK/H/PSUR/0073/001 ","April 2011","http://db.cbg-meb.nl/veegactie/csp/Famciclovir_apr_2011.pdf",null,null,"N",null,"FT4"]
["Famotidine","CSP",null,"August 2009","http://db.cbg-meb.nl/veegactie/csp/Famotidine-082009.pdf",null,null,"N",null,"FT4"]
["Favirab","Paediatric WS art 46","RO/W/0002/pdWS/001","September2012","http://db.cbg-meb.nl/veegactie/csp/Favirab_September2012.pdf",null,null,"N",null,"FT4"]
["felbamate","PhVWP recommendation",null,"July 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/anti-epileptics-and-suicidal-behaviour-lamotrigine-2008.pdf","A","July 2008","FT1"]
["felodipine","Paediatric WS art 45",null,"October 2009","CMD website",null,null,"N",null,"FT2"]
["felodipine","CSP"," SK/H/PSUR/0006/001","October 2011","http://db.cbg-meb.nl/veegactie/CSP/felodipineOctober2011.pdf",null,null,"N",null,"FT2"]
["felodipine+metoprolol","CSP","SE/H/PSUR/0038/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/felodipine-metoprolol-Oct2010.pdf",null,null,"N",null,"FT2"]
["fenobarbital","PhVWP recommendation",null,"February 2012","CMD website","2012-04-01","http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","C","February 2012","FT1"]
["fenofibrate","Art 31 referral",null,"February 2011","EU commission website",null,"EU commission website","A","March 2011","FT2"]
["Fentanyl","PRAC recommendation",null,"April 2014","http://db.cbg-meb.nl/veegactie/csp/Fentanyl_april2014.pdf",null,null,"N",null,"FT1"]
["fentanyl citrate i.v.","CSP","NL/H/PSUR/0030/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/fentanyl-citrate-iv-Oct2010.pdf",{"$nulls":4},"FT1"]
["fentanyl transdermal patches","CSP","NL/H/PSUR/0030/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/fentanyl-transdermal-patches-Oct2010.pdf",{"$nulls":4},"FT1"]
["fenytoine","PhVWP recommendation",null,"July 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/anti-epileptics-and-suicidal-behaviour-lamotrigine-2008.pdf","A","July 2008","FT1"]
["fenytoine","PhVWP recommendation",null,"November 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Fenytoine_Nov_2009.pdf","A",null,"FT1"]
["fenytoine","PhVWP recommendation",null,"February 2012","CMD website","2012-04-01","http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","C","February 2012","FT1"]
["fenytoine","PhVWP recommendation",null,"October 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","C","February 2012","FT1"]
["ferumoxsil","CSP"," DK/H/PSUR/0044/001","2011-02-01","http://db.cbg-meb.nl/veegactie/CSP/ferumoxsil-Febr2011.pdf",null,null,"N",null,"FT2"]
["Fexofenadine","Paediatric WS art 45",null,"August 2006","CMD website",null,null,"N",null,"FT3"]
["Fexofenadine","CSP","UK/H/PSUR/0054/002","July 2013","http://db.cbg-meb.nl/veegactie/csp/Fexofenadine_jul2013.pdf",null,null,"N",null,"FT3"]
["filgrastim","PRAC Signal",null,"March 2013","EMA website","30 days",null,"A","Oct 2013","FT3"]
["Finasteride","CSP",null,"December 2009","http://db.cbg-meb.nl/veegactie/csp/Finasteride-dec2009.zip",null,null,"N",null,"FT4"]
["Finasteride","CSP","SE/H/PSUR/0002/006","16 May 2014","http://db.cbg-meb.nl/veegactie/csp/Finasteride_Mei_2014.pdf",null,null,"N",null,"FT4"]
["Finasteride","PSUR WS","SE/H/PSUR/0002/006","augustus 2014","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/finasteride_SAR_2014_07.pdf",null,null,"N",null,"FT4"]
["flecanaide acetate","CSP"," NO/H/PSUR/0005/001","November 2011","http://db.cbg-meb.nl/veegactie/CSP/Flecainide-Acetate-November2011.pdf",null,null,"N",null,"FT2"]
["Fluarix","Paediatric WS art 46","DE/W/0054/pdWS/002-005","June 2013","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Fluarix_Jun2013.pdf","N",null,"FT4"]
["Flubendazole","CSP ",null,"September 2010","http://db.cbg-meb.nl/veegactie/csp/Flubendazole-sep2009.pdf",null,null,"N",null,"FT4"]
["Flucloxacilline","CMDh wording",null,"june 2014","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Product_Information/CMDh_Recommendations/CMDh_315_2014_2014_06a.pdf","CMDh-website",null,"N","01 juli 2015","FT4"]
["Fluconazol","CSP",null,"March 2009","http://db.cbg-meb.nl/veegactie/csp/Fluconazol-March2009.pdf",null,null,"N",null,"FT4"]
["Fluconazol","Art 30 referral",null,"2011-09-01","EU commission website",null,null,"A","November 2011","FT4"]
["Fluconazol","CSP"," DK/H/PSUR/0008/002","March 2012","http://db.cbg-meb.nl/veegactie/csp/Fluconazol_mrt_2012.pdf",null,null,"N",null,"FT4"]
["Fludarabine","CSP"," UK/H/PSUR/0047/001","Mei 2010","http://db.cbg-meb.nl/veegactie/csp/Fludarabine-mei2010.pdf",null,null,"N",null,"FT3"]
["fludeoxyglucose (18F)","core SmPC and PL",null,"July 2012",null,"EMA website",null,"A",null,"FT2"]
["flufenazine","PhVWP recommendation",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["flufenazine decanoate","PhVWP recommendation",null,"July 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antipsychotica_brief_registratiehouders.pdf","A",null,"FT1"]
["Flumazenil","CSP","NL/H/PSUR/0055/001","July 2010","http://db.cbg-meb.nl/veegactie/csp/Flumazenil-7-2010.pdf",null,null,"N"]
["flumazenil","CSP","NL/H/PSUR/0055/001","July 2010","http://db.cbg-meb.nl/veegactie/csp/Flumazenil-Jul2010.pdf",null,null,"N",null,"FT1"]
["Flumazenil","Paediatric WS art 45","IE/W/0006/pdWS/001 ","Feb 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/flumazenil_Feb2012.pdf","N",null,"FT1"]
["Flumazenil","PSUR WS","NL/H/PSUR/0055/002","februari 2014","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/Flumazenil_SAR_2014_04.pdf",null,null,null,"februari 2014","FT1"]
["flunarizine        ","CSP ","ES/H/PSUR/0013/001","December 2010","http://db.cbg-meb.nl/veegactie/csp/Flunarizine-December2010.pdf",null,null,"N",null,"FT1"]
["Flunitrazepam (ampoules)","CSP","  IE/H/PSUR/0039/001","January 2012","http://db.cbg-meb.nl/veegactie/CSP/CSP_Rohypnol_ampoules_Final.pdf",null,null,"N",null,"FT1"]
["Flunitrazepam (tablets)","CSP","  IE/H/PSUR/0039/001","January 2012","http://db.cbg-meb.nl/veegactie/CSP/CSP_Rohypnol_tablets_Final.pdf",null,null,"N",null,"FT1"]
["Fluoroquinolones","PRAC recommendation",null,"Juni 2014","http://db.cbg-meb.nl/veegactie/csp/Fluoroquinolones_juni2014.pdf",null,null,"N",null,"FT4"]
["Fluoroquinonlonen","PhVWP recommendation ",null,"December 2010","CMD website",null,null,"A","February 2011","FT4"]
["fluoxetine","PhVWP recommendation ",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["fluoxetine","Art 31 referral",null,"August 2005","EU commission website",null,"EU commission website","A",null,"FT1"]
["fluoxetine","Art 30 referral",null,"May 2003","EU commission website",null,"EU commission website","N",null,"FT1"]
["Fluoxetine","PhVWP recommendation ",null,"March 2010","CMD website",null,null,"A","June 2010","FT1"]
["Fluoxetine","PhVWP recommendation ",null,"March 2012","CMD website","August 2012","http://db.cbg-meb.nl/veegactie/nlvert/SSRIs_increased_ risk_ of_male_infertilityMar2012.pdf","A",null,"FT1"]
["fluoxetine               ","CSP ",null,"November 2010","http://db.cbg-meb.nl/veegactie/csp/Fluoxetine-November2010.pdf",null,null,"N",null,"FT1"]
["flupentixol dihydrochloride","PhVWP recommendation ",null,"July 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antipsychotica_brief_registratiehouders.pdf","A",null,"FT1"]
["flupentixol dihydrochloride/flupentixol decanoaat","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["fluspirileen","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["Flutamide","CSP",null,"May 2010","http://db.cbg-meb.nl/veegactie/csp/Flutamide.pdf",null,null,"N",null,"FT3"]
["Fluticason","Paediatric WS art 45",null,"July 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Fluticason.pdf","N",null,"FT3"]
["Fluticason propionaat","CSP"," UK/H/PSUR/0058/001","April 2012","http://db.cbg-meb.nl/veegactie/csp/Fluticasopropionaat-April2012.pdf",null,null,"N",null,"FT1 en FT3"]
["Fluticasone","PSUR WS","UK/H/PSUR/0058/002","1 december 2014","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/fluticasone.pdf",null,null,"N"]
["Fluticasone/Salmeterol","CSP"," SE/H/PSUR/0005/005","July 2012","http://db.cbg-meb.nl/veegactie/csp/Fluticasone-salmeterol_Jul2012.pdf",null,null,"N",null,"FT3"]
["fluvastatine","Paediatric WS art 45",null,"July 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Fluvastatine-juli2008.pdf","A","February 2010","FT2"]
["fluvastatine","PhVWP recommendation",null,"October 2009","CMD website","Implementation until June 2010","http://db.cbg-meb.nl/veegactie/nlvert/statines-Oct2009.pdf","A","February 2010","FT2"]
["fluvastatine","Art 30 referral",null,"March 2010","EU commission website",null,"EU commission website","A","February 2010","FT2"]
["fluvastatine","PhVWP recommendation",null,"February 2012","CMD website","Implementation until May 2012","http://db.cbg-meb.nl/veegactie/nlvert/Statine-March2012.pdf","A","March 2012","FT2"]
["fluvoxamine","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["fluvoxamine","Art 31 referral ",null,"August 2005","EU commission website",null,"EU commission website","A",null,"FT1"]
["fluvoxamine","Art 30 referral",null,"May 2002","EU commission website",null,"EU commission website","N",null,"FT1"]
["Fluvoxamine","PhVWP recommendation",null,"March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/SSRIs-muv-Fluoxetine-5-2010.pdf","A","June 2010","FT1"]
["fluvoxamine","CSP",null,"May 2011","http://db.cbg-meb.nl/veegactie/csp/Fluvoxamine-May2011.pdf",null,null,"N",null,"FT1 "]
["Fluvoxamine","PhVWP recommendation ",null,"March 2012","CMD website","August 2012","http://db.cbg-meb.nl/veegactie/nlvert/SSRIs_increased_ risk_ of_male_infertilityMar2012.pdf","A",null,"FT1"]
["Formoterol","CSP","SE/H/PSUR/009/002","February 2012","http://db.cbg-meb.nl/veegactie/csp/Formoterol_Feb2012.pdf",null,null,"N",null,"FT3"]
["Foscarnet","Paediatric WS art 45"," DK/W/016/pdWS/001","July 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Foscanet-Jul2012.pdf","N",null,"FT4"]
["Foscavir","CSP","NL/H/PSUR/0060/001","2013-04-01","http://db.cbg-meb.nl/veegactie/csp/Foscavir_Apr2013.pdf",null,null,"N",null,"FT4"]
["fosinopril","Paediatric WS art 45",null,"July 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/fosinopril-juli2008.pdf","A","April 2009","FT2"]
["fosinopril","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","A","April 2009","FT2"]
["fosinopril ","CSP ","ES/H/PSUR/0019/001","November 2010","http://db.cbg-meb.nl/veegactie/csp/Fosinopril-nov2010.pdf",null,null,"N",null,"FT2"]
["fosinopril +HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["fosinopril/HCT","CSP ","ES/H/PSUR/0018/001","November 2010","http://db.cbg-meb.nl/veegactie/csp/Fosinopril-HCT-nov2010.pdf",null,null,"N",null,"FT2"]
["Foxefenadine HCl","CSP",null,"July 2010",null,null,null,"N",null,"FT3"]
["Fusidic acid and sodium fusidate","CSP","HU/H/PSUR/0032/001","04 november 2014","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/Fusidic_acid_SAR_2014_10.pdf",null,null,"N",null,"FT4"]
["gabapentine","PhVWP recommendation",null,"July 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/anti-epileptics-and-suicidal-behaviour-lamotrigine-2008.pdf","A","July 2008","FT1"]
["gabitril             ","CSP ",null,"December 2010","http://db.cbg-meb.nl/veegactie/csp/gabitril-December2010.pdf",null,null,"N",null,"FT1"]
["gadobutrol","CSP",null,"December 2009","http://db.cbg-meb.nl/veegactie/csp/gadobutrol-dec2009.pdf",null,null,"N",null,"FT2"]
["gadolinium","Art 31 referral",null,"1 July 2010","CMD website",null,"CMD website","A","November 2010","FT2"]
["gadoteric acid (intraarticular)","CSP"," NL/H/PSUR/0003/002","November 2011","http://db.cbg-meb.nl/veegactie/csp/gadoteric acid_intraarticular-nov2011.pdf",null,null,"N",null,"FT2"]
["gadoteric acid (intravenous)","CSP"," NL/H/PSUR/0007/002","July 2011","http://db.cbg-meb.nl/veegactie/csp/gadoteric acid_intravenous-july2011.pdf",null,null,"N",null,"FT2"]
["gadoteridol","CSP ","DK/H/PSUR/0030/001","November 2010","http://db.cbg-meb.nl/veegactie/csp/Gadoteridol-CSP-Nov2010.pdf",null,null,"N",null,"FT2"]
["galantamine","CSP","SE/H/PSUR/0044/002","March 2013","http://db.cbg-meb.nl/veegactie/csp/Galantamine_March2013.pdf",null,null,"N",null,"FT1"]
["Gemcitabine","Paediatric WS art 45",null,"December 2005","CMD website",null,null,"N",null,"FT3"]
["Gemcitabine","CSP ","SE/H/PSUR/0043/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/Gemcitabine-Oct2010.pdf",null,null,"N",null,"FT3"]
["Gemcitabine","PSUR WS","SE/H/PSUR/0043/002","March 2014","http://db.cbg-meb.nl/veegactie/csp/Gemcitabine_mrt2014.pdf",null,null,"N",null,"FT3"]
["gemfibrozil","Art 31 referral",null,"February 2011","EU commission website",null,"EU commission website","A","March 2011","FT2"]
["Genotropin","CSP ",null,"March 2010","http://db.cbg-meb.nl/veegactie/csp/Genotropin-mrt2010.pdf",null,null,"N",null,"FT4"]
["Gentamicin sulphate","Paediatric WS art 45"," DE/W/003/pdWS/001","October 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Gentamicine-Oct2010.pdf","N",null,"FT4"]
["gestodeen + EE","CSP",null,"December 2009","http://db.cbg-meb.nl/veegactie/csp/gestodeenEE-dec2009.pdf",null,null,"N",null,"FT2"]
["Glatiramer acetate","Paediatric WS art 45","NL/W/0039/PdWS/001","August 2013",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/Art45_Glatiramer.pdf","N",null,"FT1"]
["glimepiride","PhVWP recommendation ",null,"December 2008","CMD website","Active implementation ","http://db.cbg-meb.nl/veegactie/nlvert/glimepiride.pdf","A","March 2009","FT2"]
["glimepiride","CSP","NL/H/PSUR/0034/002","May 2013","http://db.cbg-meb.nl/veegactie/csp/glimepiride-May2013.pdf",null,null,"N",null,"FT2"]
["goserelin","PhVWP recommendation",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/GnRH-March2012.pdf","A","April 2012","FT2"]
["Goserelin","PRAC recommendation",null,"Maart 2014","http://db.cbg-meb.nl/veegactie/csp/Goserelin_maart2014.pdf",null,null,"N",null,"FT2"]
["Granisetron","Art 30 referral",null,"July 2011","EU commission website",null,"EU commission website","A",null,"FT3"]
["Granisetron","Art 30 Referral",null,"Juli 2011","Commission Decision",null,null,"N",null,"FT3"]
["Granisetron","PRAC recommendation","EMA/H/C/002296/PSUV/0030","May 2014","http://db.cbg-meb.nl/veegactie/csp/Granisetron_May2014.pdf",null,null,"N",null,"FT3"]
["Haloperidol","Art 45","FR/W/011/pdWS/001","January 2012","CDM webiste",null,"http://db.cbg-meb.nl/veegactie/nlvert/Art45_haloperidol_jan2012.pdf","N",null,"FT1"]
["haloperidol/haloperidol decanoaat","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["histrelin","PhVWP recommendation",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/GnRH-March2012.pdf","A","April 2012","FT2"]
["Hormone Replacement Therapy","core SmPC and PL",null,"December 2009 (revision July 2012)","CMD website","Passive implementation, until August 2011 ","http://db.cbg-meb.nl/veegactie/nlvert/","N",null,"FT2"]
["Hormone Replacement Therapy","core SmPC and PL",null,"July 2011 ((revision July 2012)","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/HRT-corePL-July2012.pdf","N",null,"FT2"]
["hydrochlorothiazide","PhVWP recommendation",null,"March 2009","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["hydrochlorothiazide","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["hydromorfon ","Art 31 referral",null,"20 April 2011","EU commission website",null,"EU commission website","A","20 April 2011","FT1"]
["Hydrotalcite","CSP ",null,"October 2010","http://db.cbg-meb.nl/veegactie/csp/Hydrotalcite-oct2010.pdf",null,null,"N",null,"FT4"]
["Hydroxychloroquine","Paediatric WS art 45"," UK/W/029/pdWS/001","June 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Hydroxychloroquine-Jun2012.pdf","N",null,"FT4"]
["hydroxychloroquine","PRAC Signal",null,"Sept 2013","EMA website","60 days",null,"A","Oct 2013","FT4"]
["ibandronic acid","Art 20 referral",null,"July 2011","CMD website",null,"CMD website","A","August 2011","FT2"]
["ibuprofen","PhVWP recommendation",null,"June 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Ibuprofen 2008 NE en EN teksten 01-12-08.pdf","A",null,"FT1"]
["ibutilide fumarate","CSP","SE/H/PSUR/0035/001","September 2010","http://db.cbg-meb.nl/veegactie/csp/Ibutilide-Sept2010.pdf",null,null,"N",null,"FT2"]
["Idarubicin","CSP"," AT/H/PSUR/0005/002","Februari 2012","http://db.cbg-meb.nl/veegactie/csp/Idarubicin-Feb2012.pdf",null,null,"N",null,"FT3"]
["Imipenem/Cilastine","Art 30 referral",null,"March 2011","EU commission website",null,null,"A","Oct 2011","FT4"]
["imipramine","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["Imipramine","PhVWP recommendation ",null,"March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/TCAs-5-2010.pdfm","A","June 2010","FT1"]
["Inactivated Influenza Split Trivalent/ Tetravalent Vaccine","CSP","DE/H/PSUR/0049/002","30 januari 2015","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/Influenza_vaccine_split_virion_inactivated_2015_01.pdf",null,null,"N",null,"FT4"]
["indium 111 chloride","CSP ","HU/H/PSUR/0013/001","December 2010","http://db.cbg-meb.nl/veegactie/csp/indium-chloride-december2010.pdf",null,null,"N",null,"FT2"]
["indium 111 oxine","CSP",null,"January 2010","http://db.cbg-meb.nl/veegactie/csp/Indium-111-oxine-solution-Jan2010.pdf",null,null,"N",null,"FT2"]
["indium+pentetreotide","Paediatric WS art 45",null,"November 2011",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/Indium-pentetreotide _november2011.pdf","N",null,"FT2"]
["Interferon alfa 2a","CSP","NL/H/PSUR/0044/002","wacht op CMD decision","http://db.cbg-meb.nl/veegactie/csp/interferon_alfa2a_okt2014.pdf",null,null,"N",null,"FT4"]
["Interleukin-2","CSP"," NL/H/PSUR/0018/002","August 2012","http://db.cbg-meb.nl/veegactie/csp/Interleukin2-Aug2012.pdf",null,null,"N",null,"FT3"]
["iodixanol","CSP","HU/H/PSUR/0009/001","September 2010","http://db.cbg-meb.nl/veegactie/csp/iodixanol-Sept2010.pdf",null,null,"N",null,"FT2"]
["iohexol","CSP"," NO/H/PSUR/0004/001","June 2011","http://db.cbg-meb.nl/veegactie/CSP/iohexol-June2011.pdf",null,null,"N",null,"FT2"]
["iomeprol","CSP"," NO/H/PSUR/0013/001","March 2010","http://db.cbg-meb.nl/veegactie/CSP/Iomeprol-March2010.pdf",null,null,"N",null,"FT2"]
["iopamidol","CSP"," IE/H/PSUR/0016/001","November 2011","http://db.cbg-meb.nl/veegactie/CSP/IOPAMIDOL-August2011.pdf",null,null,"N",null,"FT2"]
["Iopamidol","CSP"," IE/H/PSUR/0016/002","August 2012","http://db.cbg-meb.nl/veegactie/csp/Iopamidol-aug2012.zip",null,null,"N",null,"FT2"]
["Ipratropium/Fenoterol","CSP ","NL/H/PSUR/0046/001 ","November 2010","http://db.cbg-meb.nl/veegactie/csp/Ipratropium-bromide-plus-fenoterol-hydrobromide-Nov2010.pdf",null,null,"N",null,"FT3"]
["irbesartan","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["irbesartan-HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["Irinotecan","CSP","FR/H/PSUR/0009/001","July 2011","http://db.cbg-meb.nl/veegactie/csp/Irinotecan_Jul2011.pdf",null,null,"N",null,"FT3"]
["Isoflurane","CSP"," NO/H/PSUR/0015/001","March 2011","http://db.cbg-meb.nl/veegactie/CSP/isoflurane-Mar2011.pdf",null,null,"N",null,"FT1"]
["isoflurane","CSP","NO/H/PSUR/0015/001","March 2011","http://db.cbg-meb.nl/veegactie/csp/isoflurane-Mar2011.pdf",null,null,"N",null,"FT2"]
["Isotretinoïne","Art 30 referral",null,"October 2003","EU commission website",null,"EU commission website","A",null,"FT1"]
["Isotretinoïne","PhVWP recommendation",null,"March 2010","CMD website",null,null,"A","June 2010","FT1"]
["Isotretinoïne","CSP"," UK/H/PSUR/0012/001","March 2011","http://db.cbg-meb.nl/veegactie/CSP/Isotretinoine-CSP-Mar2011.pdf",null,null,"N",null,"FT1"]
["isradipine","CSP"," CZ/H/PSUR/0019/001","May 2011","http://db.cbg-meb.nl/veegactie/csp/isradipine-Febr2011.pdf",null,null,"N",null,"FT2"]
["isradipine","Paediatric WS art 45",null,"June 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/isradipine-June2011.pdf","N",null,"FT2"]
["Itraconazol","CSP ",null,"July 2010","http://db.cbg-meb.nl/veegactie/csp/Itraconazol-jul2010.zip",null,null,"N",null,"FT4"]
["Itraconazol","Paediatric WS art 45"," EE/W/0004/pdWS/001","March 2011","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h28430.pdf","N",null,"FT4"]
["ketanserin","CSP","NL/H/PSUR/0039/002","May 2013","http://db.cbg-meb.nl/veegactie/csp/Ketanserin-May2013.pdf",null,null,"N",null,"FT2"]
["Ketobemidon","CSP","NO/H/PSUR/0002/002","May 2012","http://db.cbg-meb.nl/veegactie/csp/ketobemidon_May2012.pdf",null,null,"N",null,"FT1"]
["Ketoconazol","CSP ","CZ/H/PSUR/0010/001","December 2010","http://db.cbg-meb.nl/veegactie/csp/Ketoconazol-dec2010.zip",null,null,"N",null,"FT4"]
["Ketoconazole","Paediatric WS art 45","DK/W/0012/pdWS/001","March2012","http://db.cbg-meb.nl/veegactie/csp/Ketoconazole_March2013.pdf",null,null,"N",null,"FT4"]
["Ketoconazole","CSP","CZ/H/PSUR/0010/002","July 2013","http://db.cbg-meb.nl/veegactie/csp/Ketoconazole_Jul2013.pdf",null,null,"N",null,"FT4"]
["Ketoprofen","CSP","SE/H/PSUR/0028/002","January 2014","http://db.cbg-meb.nl/veegactie/csp/Ketoprofen_Jan2014.pdf",null,null,"N",null,"FT1"]
["ketorolac","CSP"," DK/H/PSUR/0038/001 ","June 2011 (revision CSP January 2012)","http://db.cbg-meb.nl/veegactie/CSP/ketorolac-CSP-11JAN2012.pdf",null,null,"N",null,"FT1"]
["Ketotifen","CSP","IT/H/PSUR/0006/002","January 2014","http://db.cbg-meb.nl/veegactie/csp/Ketotifen_Jan2014.pdf",null,null,"N",null,"FT3"]
["ketotifen - eye drops","CSP",null,"March 2010","http://db.cbg-meb.nl/veegactie/csp/ketotifen-eyedrops-3-2010.pdf",null,null,"N",null,"FT1"]
["Lacidipine","CSP","EE/H/PSUR/0002/002","Juni 2012"]
["Lactitol monohydraat","CSP ",null,"May 2010","http://db.cbg-meb.nl/veegactie/csp/Lactitol-May2010.pdf",null,null,"N",null,"FT4"]
["Lactitol monohydrate","CSP","AT/H/PSUR/0019/002","July 2013","http://db.cbg-meb.nl/veegactie/csp/Lactitol monohydrate_Jul2013.pdf",null,null,"N",null,"FT4"]
["Lamotrigine","WS Art 45","NL/W/003/pdWS/001","Jul2013","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Art45_lamotrigine_July 2013.pdf",null,null,"FT1"]
["lamotrigine","CSP","NL/H/PSUR/0042/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/lamotrigine-Oct2010.pdf",null,null,"N",null,"FT1"]
["lamotrigine","PhVWP recommendation",null,"October 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","C","February 2012","FT1"]
["Lamotrigine ","PhVWP recommendation",null,"February 2012","CMD website","2012-04-01","http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","A","February 2012","FT1"]
["lamotrigine ","CSP ","NL/H/PSUR/0042/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/lamotrigine-October2010.pdf",null,null,"N",null,"FT1"]
["Lanreotide","CSP",null,"September 2009","http://db.cbg-meb.nl/veegactie/csp/Lanreotide.pdf",null,null,"N",null,"FT4"]
["Lansoprazol","Others",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/PPI_botfractuur_maart2012.pdf","A","April 2012","FT4"]
["Lansoprazol","Class effects of proton-pump inhibitors on magnesium blood levels in long-term users",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/PPI_hypomagnesiemie_maart2012.pdf","A","April 2012","FT4"]
["Lansoprazol ","Paediatric WS art 45"," DE/W/006/pdWS/001","August 2010","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h15420.pdf","N",null,"FT4"]
["Latanoprost","Art 29 referral",null,"October 2010","EU commission website",null,"EU commission website","N",null,"FT1"]
["latanoprost ","CSP",null,"January 2010","http://db.cbg-meb.nl/veegactie/csp/latanoprost-1-2010.pdf",null,null,"N",null,"FT1"]
["Latanoprost + timolol ","CSP"," SE/H/PSUR/0010/002","Mar 2012","http://db.cbg-meb.nl/veegactie/csp/Latanoprost_timolol_Mar2012.pdf",null,null,"N",null,"FT1"]
["Leflunomide","PRAC signal",null,"November 2013","EMA website",null,null,"N",null,"FT1"]
["Lenograstim","PRAC recommendation","EMA/PRAC/663212/2013","November 2013",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/Lenograstim_nov2013.pdf","A",null,"FT3"]
["Letrozol","Art 30 referral",null,"May 2012","Commission Decision",null,null,"N",null,"FT3"]
["leuprorelin","PhVWP recommendation",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/GnRH-March2012.pdf","A","April 2012","FT2"]
["Levetiracetam","PRAC signal",null,"November 2013","EMA website",null,null,"N",null,"FT1"]
["levobunolol","PhVWP recommendation",null,"January 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Beta_blocking_agents_January2012.pdf","N",null,"FT1"]
["Levobunolol","CSP","CZ/H/PSUR/0006/002","July 2012","http://db.cbg-meb.nl/veegactie/csp/Levobunolol_jul2012.pdf",null,null,"N",null,"FT1"]
["levocabastine","Paediatric WS art 45","DE/W/062/pdWS/001","20 Oktober 2014",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/Levocabastine_oktober2014.pdf","N",null,"FT3"]
["Levocabastine","Paediatric WS art 45","DE/W/062/pdWS/001","20 oktober 2014","http://db.cbg-meb.nl/veegactie/csp/Levocabastine_okt2014.pdf",null,null,"N"]
["Levodopa (incl. combinations)","PhVWP recommendation ",null,"July 2012","CMD website","2012-11-01","http://db.cbg-meb.nl/veegactie/nlvert/Levodopa_Jul2012.pdf","A",null,"FT1"]
["Levofloxacine","Art 30 referral","EMEA/H/A-30/1262","August 2012","EU commission website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Levofloxacine_Jul2012.pdf","N",null,"FT4"]
["levomepromazine waterstofmaleaat/levomepromazine hydrochloride","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["Levothyroxine","Paediatric WS art 45"," DE/W/026/pdWS/001","November 2010","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h08389.pdf","N",null,"FT4"]
["Lidocaine","Paedatric WS art 45","SE/W/008/pdWS/001","July 2013","CMD website","x","http://db.cbg-meb.nl/veegactie/nlvert/Lidocaine_Jul2013.pdf","N",null,"FT4"]
["lidocaine + prilocaine","CSP",null,"April 2010","http://db.cbg-meb.nl/veegactie/csp/lidocaine-prilocaine-4-2010.pdf",null,null,"N",null,"FT1"]
["Linezolide","CSP ","UK/H/PSUR/0037/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/Linezolide-oct2010.pdf",null,null,"N",null,"FT4"]
["lisinopril","CSP",null,"July 2008","http://db.cbg-meb.nl/veegactie/csp/lisinopril-July2008.pdf",null,null,"N",null,"FT2"]
["lisinopril","Paediatric WS art 45",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Lisinopril.pdf","N",null,"FT2"]
["lisinopril","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["lisinopril","CSP"," PT/H/PSUR/0014/001","July 2011","http://db.cbg-meb.nl/veegactie/CSP/Lisinopri-July2011.pdf",null,null,"N",null,"FT2"]
["lisinopril-HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["lisinopril-HCT","CSP","PT/H/PSUR/0015/001","April 2013","http://db.cbg-meb.nl/veegactie/csp/lisinopril_HCTApril2013.pdf",null,null,"N",null,"FT2"]
["Lisuride","PhVWP recommendation ",null,"July 2012","CMD website","Nov 2012","http://db.cbg-meb.nl/veegactie/nlvert/Divers_PhVWP_risk_of_impils_control_disorders_Jul2012.pdf","A",null,"FT1"]
["Livostin","CSP","DK/H/PSUR/0025/001","November 2010","http://db.cbg-meb.nl/veegactie/csp/livostin-nov2010.zip",null,null,"N",null,"FT3"]
["Lofepramine","PhVWP recommendation ",null,"March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/TCAs-5-2010.pdf","A","June 2010","FT1"]
["Lomustine","CSP","SK/H/PSUR/0007/001","June 2012","http://db.cbg-meb.nl/veegactie/csp/Lomustine_Jun2012.pdf",null,null,"n",null,"FT3"]
["Loperamide","CSP","PL/H/PSUR/0012/002","december 2013","http://db.cbg-meb.nl/veegactie/csp/Loperamide_febr2014.pdf",null,null,"N",null,"FT4"]
["Loperamide ","CSP"," PL/H/PSUR/0012/001","January 2011","http://db.cbg-meb.nl/veegactie/CSP/Loperamide_jan_2011.pdf",{"$nulls":4},"FT4"]
["Loratadine","CSP",null,"June 2010","http://db.cbg-meb.nl/veegactie/csp/Loratadine-june2010.pdf",null,null,"N",null,"FT3"]
["Lormetazepam","CSP","AT/H/PSUR/0030/001","October 2012","http://db.cbg-meb.nl/veegactie/csp/Lormetazepam_Oct2012.pdf",null,null,"N",null,"FT1"]
["losartan","Art 30 referral",null,"April 2008","EU commission website",null,"EU commission website","A","September 2009","FT2"]
["losartan","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","A","September 2009","FT2"]
["losartan","CSP"," NL/H/PSUR/0056/001","June 2011","http://db.cbg-meb.nl/veegactie/csp/Losartan-June2011.pdf",null,null,"N",null,"FT2"]
["losartan-HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","A",null,"FT2"]
["losartan-HCT","Art 30 referral",null,"April 2008","EU commission website",null,"EU commission website","A",null,"FT2"]
["losartan-HCT","CSP ","NL/H/PSUR/0057/001","December 2010","http://db.cbg-meb.nl/veegactie/csp/Losartan-HCT-december2010.pdf",null,null,"N",null,"FT2"]
["Lysine acetylacetaat","CSP ",null,"August 2010","http://db.cbg-meb.nl/veegactie/csp/Lysine-acetylsalicylate-aug2010.pdf",null,null,"N",null,"FT1"]
["Macrogol 4000","CSP ","FR/H/PSUR/0062/001","November 2010","http://db.cbg-meb.nl/veegactie/csp/Macrogol-4000-nov2010.zip",null,null,"N",null,"FT4"]
["maprotiline","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["mebrofenin for labelling with 99mTc ","CSP","DK/H/PSUR/0047/001","July 2010","http://db.cbg-meb.nl/veegactie/csp/mebrofenin-July 2010.pdf",null,null,"N",null,"FT2"]
["Mefloquine","CSP","DE/H/PSUR/0022/001","April 2013","http://db.cbg-meb.nl/veegactie/csp/Mefloquine_Apr2013.pdf",null,null,"N",null,"FT4"]
["Mefloquine","PRAC signal",null,"February 2014","EMA website",null,null,"N"]
["Mefloquine","PSUR WS","DE/H/PSUR/0022/002","augustus 2014","http://db.cbg-meb.nl/veegactie/csp/Mefloquine_aug2014.pdf",null,null,"N","22 januari 2015","FT4"]
["meloxicam","PhVWP recommendation",null,"October 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","N","February 2012","FT1"]
["Meloxicam","CSP","  FR/H/PSUR/0001/001","December 2011","http://db.cbg-meb.nl/veegactie/csp/meloxicam_Dec_2011.pdf",null,null,"N",null,"FT1"]
["mepivacaine","Paediatric WS art 45"," AT/W/0002/pdWS/001 ","August 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Mepivacain-August2010.pdf","N",null,"FT1"]
["Meropenem","Art 30 referral",null,"October 2009","EU commission website",null,"EU commission website","N",null,"FT4"]
["Meropenem","CSP","AT/H/PSUR/0018/002","July 2013","http://db.cbg-meb.nl/veegactie/csp/Meropenem_Jul2013.pdf",null,null,"N",null,"FT4"]
["Mesalazine","Paediatric WS art 45"," DK/W/001/pdWS/001","March 2010","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h14797.pdf","N",null,"FT4"]
["mesalazine","CSP"," UK/H/PSUR/0052/001","April 2011","http://db.cbg-meb.nl/veegactie/csp/Mesalazine_April2011.pdf",null,null,"N",null,"FT4"]
["metformine","CSP",null,"March 2010","http://db.cbg-meb.nl/veegactie/csp/Metformin-March 2010.pdf",null,null,"N",null,"FT2"]
["methylaminolevulinate","CSP",null,"April 2010","http://db.cbg-meb.nl/veegactie/csp/methylaminolevulinate-4-2010.pdf",null,null,"N",null,"FT1"]
["methylfenidaat","Art 31 referral",null,"May 2009","EU commission website",null,"EU commission website","A",null,"FT1"]
["Methylfenidaat","CSP","UK/H/PSUR/0068/002&3","September 2012","http://db.cbg-meb.nl/veegactie/csp/methylphenidate_sep2012.pdf",null,null,"N",null,"FT1"]
["Methylprednisolon","CSP",null,"November 2009","http://db.cbg-meb.nl/veegactie/csp/Methylprednisolone-031109.pdf",null,null,"N",null,"FT4"]
["metipranolol","PhVWP recommendation",null,"January 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Beta_blocking_agents_January2012.pdf","N",null,"FT1"]
["Metoclopramide","Art. 31 referral","EMEA/H/A-31/1321","January 2014","EU commission website",null,"EU commission website","N",null,"FT4"]
["Metoclopramide ","Paediatric WS art 45"," DE/W/007/pdWS/001","March 2011","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h05250.pdf","N",null,"FT4"]
["metoprolol","Paediatric WS art 45","NL/W/0037/pdWS/001","September 2013","CMD-website",null,null,"N",null,"FT2"]
["Metrodinazol","CSP ",null,"January 2010","http://db.cbg-meb.nl/veegactie/csp/Metrodinazol-jan2010.pdf",null,null,"N",null,"FT4"]
["Metronidazol","Paediatric WS art 45","PL/H/PSUR/0005/002","July2012","http://db.cbg-meb.nl/veegactie/csp/Metronidazole_July2012.pdf",null,null,"N",null,"FT4"]
["Metronidazole","Paediatric WS art 45"," SE/W/011/pdWS/001","January 2011","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h07074.pdf","N",null,"FT4"]
["mianserine","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["mianserine","Art 31 referral ",null,"August 2005","EU commission website",null,"EU commission website","A",null,"FT1"]
["Midazolam","CSP","FR/H/PSUR/0026/001","December 2011","http://db.cbg-meb.nl/veegactie/csp/midazolam_Dec2011.pdf",null,null,"N",null,"FT1"]
["miglitol","CSP",null,"June 2010","http://db.cbg-meb.nl/veegactie/csp/Miglitol-June2010.pdf",null,null,"N",null,"FT2"]
["Miglitol","CSP","NL/H/PSUR/0049/002","June 2013","http://db.cbg-meb.nl/veegactie/csp/Miglitol_Jun2013.pdf",null,null,"N",null,"FT2"]
["milrinone","CSP",null,"June 2010","http://db.cbg-meb.nl/veegactie/csp/Milrinone-June2010.pdf",null,null,"N",null,"FT2"]
["milrinone","Paediatric WS art 45",null,"April 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Milrinone-April2011.pdf","N",null,"FT2"]
["minoxidil","Paediatric WS art 45",null,"October 2011",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/minoxidil-oct2011.pdf","N",null,"FT2"]
["Minoxidil","CSP","IE/H/PSUR/0040/001","August 2011","http://db.cbg-meb.nl/veegactie/csp/Minoxidil_Aug2011.pdf",null,null,"N",null,"FT2"]
["mirtazapine","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["mirtazapine","Art 31 referral ",null,"August 2005","EU commission website",null,"EU commission website","A",null,"FT1"]
["mirtazapine","Art 30 referral",null,"September 2008","EU commission website",null,"http://db.cbg-meb.nl/veegactie/nlvert/SNRI-s-5-2010.pdf","N",null,"FT1"]
["mirtazapine","PhVWP recommendation",null,"March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/SNRI-s-5-2010.pdfm","A","June 2010","FT1"]
["mirtazapine","CSP"," NL/H/PSUR/0006/002","November 2011"," http://db.cbg-meb.nl/veegactie/CSP/mirtazapine-CSP-Nov2011.pdf",null,null,"N",null,"FT1"]
["Mirtazapine","Paediatric WS art 45","UK/H/0016/pdWS/001","June 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Mirtazapine-Art45_June 2010.pdf","N",null,"FT1"]
["Mirtazapine","PRAC Signal",null,"April 2013","EMA website",null,null,"A","Oct 2013","FT1"]
["Mirtazapine","PRAC signal",null,"April 2013","EMA website",null,null,"N",null,"FT1"]
["Misoprostol","CSP"," DK/H/PSUR/0014/001","January 2010","http://db.cbg-meb.nl/veegactie/CSP/Misoprostol_jan_2010.pdf",null,"CMD website","A","November 2011","FT2"]
["Mivacurium","Paediatric WS art 45"," PL/W/007/pdWS/01","2012-04-01","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Mivacurium_April2012.pdf","N",null,"FT1"]
["mivacurium ","CSP ","IE/H/PSUR/0031/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/mivacurium-October2010.pdf",null,null,"N",null,"FT1"]
["Mizolastine","CSP"," UK/H/PSUR/0040/001","March 2011","http://db.cbg-meb.nl/veegactie/CSP/Mizolastine-March2011.pdf",null,null,"N",null,"FT3"]
["Mizolastine","CSP","UK/H/PSUR/0040/001","March 2011","http://db.cbg-meb.nl/veegactie/csp/Mizolastine-March2011.pdf",null,null,"N",null,"FT3"]
["moclobemide","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["Moclobemine","CSP","NL/H/PSUR/0031/001","March 2013","http://db.cbg-meb.nl/veegactie/csp/",null,null,"N",null,"FT1"]
["mometasone + salicylic acid","CSP",null,"February 2010","http://db.cbg-meb.nl/veegactie/csp/mometasone-salicylic acid-7-2010.pdf",null,null,"N",null,"FT1"]
["mometasone + salicylic acid","CSP","SE/H/PSUR/0023/002","21 August 2013","http://db.cbg-meb.nl/veegactie/csp/Mometasone-salicylic acid_augustus2013.pdf",null,null,"N",null,"FT3"]
["mometasone    ","CSP ","UK/H/PSUR/0041/001","December 2010","http://db.cbg-meb.nl/veegactie/csp/mometasone-december2010.pdf",null,null,"N",null,"FT1"]
["Montelukast","Art 30 referral",null,null,"EU commission website",null,"EU commission website","N",null,"FT3"]
["Montelukast","CSP","FI/H/PSUR/0015/002","June 2013","http://db.cbg-meb.nl/veegactie/csp/Montelukast_jun2013.pdf",null,null,"N",null,"FT3"]
["morfine ","Art 31 referral",null,"20 April 2011","EU commission website",null,"EU commission website","A","20 April 2011","FT1"]
["moxonidine","CSP","HU/H/PSUR/0027/001","March 2013","http://db.cbg-meb.nl/veegactie/csp/moxonidine-Nov2009.pdf",null,null,"N",null,"FT2"]
["Mucoangin","CSP",null,"May 2010","http://db.cbg-meb.nl/veegactie/csp/moxonidine-March2013.pdf",null,null,"N",null,"FT3"]
["mupirocin","CSP",null,"November 2009","http://db.cbg-meb.nl/veegactie/csp/mupirocin-11-2009.pdf",null,null,"N",null,"FT1"]
["Mycofenolaat","CSP"," FR/H/PSUR/0057/001","May 2012","http://db.cbg-meb.nl/veegactie/csp/Mycofenolaat_May2012.pdf",null,null,"N",null,"FT3"]
["nabumetone","CSP",null,"January 2010","http://db.cbg-meb.nl/veegactie/csp/nabumetone_Jan_2010.pdf",null,null,"N",null,"FT1"]
["nafarelin","PhVWP recommendation",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/GnRH-March2012.pdf","A","April 2012","FT2"]
["Nafarelin","CSP"," NO/H/PSUR/0012/001","June 2011",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/nafarelin-June2011.pdf","N",null,"FT2"]
["naltrexone hydrochloride","CSP","IE/H/PSUR/0028/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/naltrexone-hydrochroride-Oct2010.pdf",{"$nulls":4},"FT1"]
["Naltrexone hydrochloride","CSP","IE/H/PSUR/0028/002","July 2013","http://db.cbg-meb.nl/veegactie/csp/Naltexone_hydrochloride_Jul2013.pdf",null,null,"N",null,"FT1"]
["naratriptan","CSP",null,"October 2009","http://db.cbg-meb.nl/veegactie/csp/naratriptan-10-2009.pdf",null,null,"N",null,"FT1"]
["Naratriptan","CSP","SE/H/PSUR/0019/002","November 2012","http://db.cbg-meb.nl/veegactie/csp/Naratriptan_nov2012.pdf",null,null,"N",null,"FT1"]
["natriumvalproaat","PhVWP recommendation",null,"February 2012","CMD website","2012-04-01","http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","A","February 2012","FT1"]
["natriumvalproaat/valproïnezuur","PhVWP recommendation",null,"July 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/anti-epileptics-and-suicidal-behaviour-lamotrigine-2008.pdf","A","July 2008","FT1"]
["natriumvalproaat/valproïnezuur","PhVWP recommendation ",null,"April 2010","http://db.cbg-meb.nl/veegactie/nlvert/Valproic-acid-natriumvalproaat- apr2010.pdf",null,null,"N","April 2010","FT1"]
["nebivolol","CSP",null,"March 2010","http://db.cbg-meb.nl/veegactie/csp/nebivolol-March2010.pdf",null,null,"N",null,"FT2"]
["Nedocromil","CSP ",null,"December 2010","http://db.cbg-meb.nl/veegactie/csp/Nedocromil-tilade-dec2010.pdf",null,null,"N",null,"FT1/3"]
["neridronic acid","Art 30 referral",null,"July 2011","EU commission website",null,"EU commission website","A","August 2011","FT2"]
["Nicardipine","PRAC Signal","thrombocytopenia","Nov 2012","EMA website","60 days",null,"A","Oct 2013","FT2"]
["Nicardipine","PRAC Signal","Acute pulmonary oedema in off-label use during pregnancy","Sept 2013","EMA website",null,null,"A","Oct 2013","FT2"]
["nicorandil","CSP","AT/H/PSUR/0023/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/Nicorandil-October2010.RTF",null,null,"N",null,"FT2"]
["nifedipine","Paediatric WS art 45",null,"December 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/","N",null,"FT2"]
["nifedipine","CSP","CZ/H/PSUR/0014/001","April 2013","http://db.cbg-meb.nl/veegactie/csp/Nifedipine-April2013.zip",null,null,"N",null,"FT2"]
["Nilutamide","CSP",null,"April 2010",null,null,null,"N",null,"FT3"]
["Nimesulide","PSUR WS","IT/H/PSUR/0023/006 ","april 2012","http://db.cbg-meb.nl/veegactie/csp/nimesulide_april2012.pdf",null,null,null,"april 2012","FT1"]
["nitrendipine","CSP",null,"February 2010","http://db.cbg-meb.nl/veegactie/csp/nitrendipine-febr2010.pdf",null,null,"N",null,"FT2"]
["nitroglycerine","CSP","IE/H/PSUR/0014/001","October 2010","http://db.cbg-meb.nl/veegactie/csp/Nitroglycerin-October2010.pdf",null,null,"N",null,"FT2"]
["Nitroglycerine","CSP","IE/H/PSUR/0014/002","June 2013","http://db.cbg-meb.nl/veegactie/csp/nitroglycerine_Jun2013.pdf",null,null,"N",null,"FT2"]
["Norditropin","CSP ",null,"January 2010","http://db.cbg-meb.nl/veegactie/csp/Norditropin-january2010.pdf",null,null,"N",null,"FT4"]
["Norfloxacine","Art 31 referral",null,"November 2009","EU commission website",null,"EU commission website","A","April 2010","FT4"]
["norgestimate + EE","CSP",null,"December 2009","http://db.cbg-meb.nl/veegactie/csp/NorgestimateEE-dec2009.pdf",null,null,"N",null,"FT2"]
["nortriptyline","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["Nortriptyline","PhVWP recommendation ",null,"March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/TCAs-5-2010.pdf","A","June 2010","FT1"]
["Octreotide","CSP"," IE/H/PSUR/0010/002","maart 2012","http://db.cbg-meb.nl/veegactie/csp/Octreotide_maart2012.zip",null,null,"N",null,"FT4"]
["Octreotide-acetaat","Art. 30 referral","EMEA/H/A-30/1355","26 August 2014","EU Commission website",null,null,"N",null,"FT4"]
["Octreotide-acetaat","Art. 30 referral","EMEA/H/A-30/1354","26 August 2014","EU Commission website",null,null,"N",null,"FT4"]
["Ofloxacin","PSUR WS","DK/H/PSUR/0053/002","Januari 2013",null,null,null,"N",null,"FT4"]
["Ofloxacin","CSP","SE/H/PSUR/0041/002","2014-11-04","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/Ofloxacin_SAR_2014_10.pdf","HMA website",null,"N",null,"FT4"]
["Ofloxacine","Paediatric WS art 45",null,"July 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Ofloxacin_Jul2008.pdf","N",null,"FT4"]
["Ofloxacine","CSP ",null,"September 2010","http://db.cbg-meb.nl/veegactie/csp/Ofloxacin-aug2010.pdf",null,null,"N",null,"FT4"]
["Ofloxacine, oogdruppels","CSP",null,"January 2010","http://db.cbg-meb.nl/veegactie/csp/Ofloxacin-oogdruppels-jan2010.pdf",null,null,"N",null,"FT4"]
["Olanzapine","PhVWP recommendation",null,"July 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antipsychotica_brief_registratiehouders.pdf","A",null,"FT1"]
["olanzapine/olanzapine-pamoatinezuur 1 -water/olazapine benzoaat","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["olmesartan","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["olmesartan medoxomil","Paediatric WS art 46","UK/W/0021/pdWS/001","November 2013","CMD-website",null,null,"N",null,"FT2"]
["olmesartan/amlodipine","CSP"," NL/H/PSUR/0053/002","March 2013","http://db.cbg-meb.nl/veegactie/csp/Olmesartan+Amlodipine-March2013.pdf",null,null,"N",null,"FT2"]
["olmesartan/amlodipine/HCT","CSP","NL/H/PSUR/0062/002","May 2013","http://db.cbg-meb.nl/veegactie/csp/olmesartan-amlodipine-HCT-May2013.pdf",null,null,"N",null,"FT2"]
["olmesartan-HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["Olsalazine","CSP","FI/H/PSUR/0014/002",{"$nulls":4},"N",null,"FT4"]
["Omeprazol","Art 30 referral",null,"2010-06-01","EU commission website",null,"EU commission website",null,null,"FT4"]
["Omeprazol","Class effects of proton-pump inhibitors on magnesium blood levels in long-term users",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/PPI_hypomagnesiemie_maart2012.pdf","A","April 2012","FT4"]
["Omeprazol","Others",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/PPI_botfractuur_maart2012.pdf","A","April 2012","FT4"]
["Omeprazol/ketoprofen","Others",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/PPI_botfractuur_maart2012.pdf","A","April 2012","FT4"]
["Ondansetron","Paediatric WS art 45",null,"December 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Ondansetron.pdf","N",null,"FT3"]
["Ondansetron","CSP"," SI/H/PSUR/0001/002","January 2013","http://db.cbg-meb.nl/veegactie/csp/Ondansetron_Jan2013.pdf",null,null,"N",null,"FT3"]
["Oxaliplatine","CSP"," FR/H/PSUR/0022/001","November 2011","http://db.cbg-meb.nl/veegactie/csp/Oxaliplatine-Nov2011.pdf",null,null,"N",null,"FT3"]
["Oxatomide","CSP","PT/H/PSUR/0005/003","September 2012","http://db.cbg-meb.nl/veegactie/csp/Oxatomide_Sep2012.pdf",null,null,"N",null,"FT3"]
["oxazepam","Paediatric WS art 45",null,"July 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Oxazepam-July2009.pdf","N",null,"FT1"]
["oxcarbazepine","PhVWP recommendation",null,"July 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/anti-epileptics-and-suicidal-behaviour-lamotrigine-2008.pdf","A","July 2008","FT1"]
["Oxcarbazepine","PhVWP recommendation",null,"February 2012","CMD website","2012-04-01","http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","A","February 2012","FT1"]
["Oxcarbazepine","PhVWP recommendation ",null,"July 2012","CMD website","2012-11-01","http://db.cbg-meb.nl/veegactie/nlvert/Oxcarbazepine_Jul2012.pdf","A",null,"FT1"]
["Oxybutynin hydrochloride","CSP","BE/H/PSUR/0014/002","30 januari 2015","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/Oxybutinin_2015_01.pdf",null,null,"N",null,"FT4"]
["Oxybutynine","Paediatric WS art 45"," UK/W/017/pdWS/001","November 2010","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h20796.pdf","N",null,"FT4"]
["Oxybutynine","CSP","BE/H/PSUR/0014/001","November 2013","http://db.cbg-meb.nl/veegactie/csp/Oxybutinin_Nov2013.pdf",null,null,"N",null,"FT4"]
["oxycodon ","Art 31 referral",null,"20 April 2011","CMD website",null,"CMD website","A","20 April 2011","FT1"]
["Oxycodone","CSP"," NL/H/PSUR/0054/001","January 2013","http://db.cbg-meb.nl/veegactie/csp/OXYCODONE_Jan2013.pdf",null,null,"N",null,"FT1"]
["Paclitaxel","CSP"," NL/H/PSUR/0045/001","March 2011","http://db.cbg-meb.nl/veegactie/CSP/Paclitaxel-March2011.pdf",null,null,"N",null,"FT3"]
["Paclitaxel","CSP","NL/H/PSUR/0045/002","4 november 2014","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/Paclitaxel_SAR_2014_10.pdf",null,null,"N",null,"FT3"]
["pamidronate","CSP"," CZ/H/PSUR/0020/001","October 2011"," http://db.cbg-meb.nl/veegactie/CSP/pamidronate-October2011.pdf",null,null,"N",null,"FT2"]
["pamidronic acid","PhVWP recommendation",null,"October 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Alendronic-acid-stress-fractures.pdf","A","March 2009","FT2"]
["pamidronic acid","Art 30 referral",null,"July 2011","EU commission website",null,"EU commission website","A","August 2011","FT2"]
["Pantoprazol","Art 30 referral",null,"April 2010","EU commission website",null,"EU commission website","A","Jun 2010","FT4"]
["Pantoprazol","Class effects of proton-pump inhibitors on magnesium blood levels in long-term users",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/PPI_hypomagnesiemie_maart2012.pdf","A","April 2012","FT4"]
["Pantoprazol","Others",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/PPI_botfractuur_maart2012.pdf","A","April 2012","FT4"]
["Pantoprazol","PSUR WS","DE/H/PSUR/0039/002","Dec 2013","http://db.cbg-meb.nl/veegactie/csp/Pantoprazol_dec2013.pdf",null,null,"N",null,"FT4"]
["Paracalcitol","CSP","ES/H/PSUR/0016/002","September 2011","http://db.cbg-meb.nl/veegactie/csp/Paracalcitol_Sep2011.pdf",null,null,"N",null,"FT4"]
["Paracetamol","PRAC signal",null,"February 2014","EMA website",null,null,"N",null,"FT1"]
["paracetamol (infusie)","PhVWP recommendation",{"$nulls":4},"http://db.cbg-meb.nl/veegactie/nlvert/Paracetamol_infuus_Apr_2012.pdf"]
["Paracetamol (oplossing voor infuus)","PhVWP recommendation",null,"April 2012",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/Paracetamol_infuus_Apr_2012.pdf","A",null,"FT1"]
["Paricalcitol","CSP","ES/H/PSUR/0016/003","19 januari 2015","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/Paricalcitol_SAR_2014_12.pdf",null,null,"N"]
["paroxetine","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["paroxetine","Art 31 referral ",null,"August 2005","EU commission website",null,"EU commission website","A",null,"FT1"]
["paroxetine","Art 30 referral",null,"March 2005","EU commission website",null,"EU commission website","A",null,"FT1"]
["Paroxetine","PhVWP recommendation",null,"March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/SSRIs-muv-Fluoxetine-5-2010.pdf","A","June 2010","FT1"]
["paroxetine","CSP"," NL/H/PSUR/0023/003","October 2010","http://db.cbg-meb.nl/veegactie/csp/Paroxetine-1July2011.pdf",{"$nulls":4},"FT1"]
["Paroxetine","PhVWP recommendation ",null,"March 2012","CMD website","August 2012","http://db.cbg-meb.nl/veegactie/nlvert/SSRIs_increased_ risk_ of_male_infertilityMar2012.pdf","A",null,"FT1"]
["pegfilgrastim","PRAC Signal",null,"March 2013","EMA website","30 days",null,"A","Oct 2013","FT3"]
["Penciclovir","CSP","UK/H/PSUR/0066/002","February 2014","http://db.cbg-meb.nl/veegactie/csp/Penciclovir_Feb2014.pdf",null,null,"N",null,"FT4"]
["Penciclovir ","CSP ","UK/H/PSUR/0066/001","August 2010","http://db.cbg-meb.nl/veegactie/csp/Penciclovir-aug2010.pdf",null,null,"N",null,"FT4"]
["penfluridol","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["penicillamine","Paediatric WS art 45","UK/W/033/pdWS/001","September 2012","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Paediatric_Regulation/Assessment_Reports/Article_45_work-sharing/Penicillamine_-_Art.45_PublicAR.pdf",{"$nulls":4},"FT4"]
["Pentamidine","CSP ",null,"February 2010","http://db.cbg-meb.nl/veegactie/csp/Pentamidine-isethionate-feb2010.pdf",null,null,"N",null,"FT4"]
["Pentamidine","Paediatric WS art 45","DK/W/020/pdWS/001","June 2013","CMD website","x","http://db.cbg-meb.nl/veegactie/nlvert/Pentamidine_Jun2013.pdf","N",null,"FT4"]
["perfenazine","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["pergolide","Art 31 referral",null,"January 2009","EU commission website",null,"EU commission website","A","January 2009","FT1"]
["Pergolide","PhVWP recommendation ",null,"July 2012","CMD website","Nov 2012","http://db.cbg-meb.nl/veegactie/nlvert/Divers_PhVWP_risk_of_impils_control_disorders_Jul2012.pdf","A",null,"FT1"]
["periciazine","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["perindopril","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["perindopril-HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["Permethrin","Paediatric WS art 45","UK/W/044/pdWS/001","October 2013",null,null,null,"N",null,"FT4"]
["phenobarbital","PhVWP recommendation",null,"October 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","C","February 2012","FT1"]
["Phytomenadione","Paediatric WS art 45","LV/W/0002/pdWS/001","April 2013","CMD website","x","http://db.cbg-meb.nl/veegactie/nlvert/Phytomenadione_Apr2013.pdf","N",null,"FT4"]
["pilocarpine","CSP",null,"February 2010","http://db.cbg-meb.nl/veegactie/csp/pilocarpine-2-2010.pdf",null,null,"N",null,"FT1"]
["pimecrolimus","CSP",null,"January 2010","http://db.cbg-meb.nl/veegactie/csp/pimecrolimus-1-2010.pdf",null,null,"N",null,"FT1"]
["pimozide","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["pipamperon dihydrocloride","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["Piperacilline/tazobactam","Art 30 referral",null,"February 2011","EU commission website",null,"EU commission website","A","Oct 2011","FT4"]
["piracetam","CSP",null,"April 2010","http://db.cbg-meb.nl/veegactie/csp/piracetam-6-2010.pdf",null,null,"N",null,"FT1"]
["Pirenzepine","CSP ","AT/H/PSUR/0001/002","August 2010","http://db.cbg-meb.nl/veegactie/csp/Pirenzepine-aug2010.pdf",null,null,"N",null,"FT4"]
["Piribedil","PhVWP recommendation ",null,"July 2012","CMD website","Nov 2012","http://db.cbg-meb.nl/veegactie/nlvert/Divers_PhVWP_risk_of_impils_control_disorders_Jul2012.pdf","A",null,"FT1"]
["piroxicam","PhVWP recommendation",null,"October 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","N","February 2012","FT1"]
["pitavastatine","PhVWP recommendation",null,"February 2012","CMD website","Implementation until May 2012","http://db.cbg-meb.nl/veegactie/nlvert/Statine-March2012.pdf","A","March 2012","FT2"]
["poglitazone","Art 20 referral",null,"December 2011","EU commission website",null,"EU commission website","N",null,"FT2"]
["povidone","CSP",null,"November 2009","http://db.cbg-meb.nl/veegactie/csp/povidone-11-2009.pdf",null,null,"N",null,"FT1"]
["Pramipexole","PhVWP recommendation ",null,"July 2012","CMD website","Nov 2012","http://db.cbg-meb.nl/veegactie/nlvert/Divers_PhVWP_risk_of_impils_control_disorders_Jul2012.pdf","A",null,"FT1"]
["pravastatine","PhVWP recommendation",null,"October 2009","CMD website","Implementation until June 2010","http://db.cbg-meb.nl/veegactie/nlvert/statines-Oct2009.pdf","A","February 2010","FT2"]
["pravastatine","PhVWP recommendation",null,"February 2012","CMD website","Implementation until May 2012","http://db.cbg-meb.nl/veegactie/nlvert/Statine-March2012.pdf","A","March 2012","FT2"]
["prazepam","PhVWP recommendation",null,"July 2012","CMD website","2012-11-01","http://db.cbg-meb.nl/veegactie/nlvert/Prazepam_Jul2012.pdf","A",null,"FT1"]
["Praziquantel","CSP","FR/H/PSUR/0041/001","January 2013","http://db.cbg-meb.nl/veegactie/csp/Praziquatel_Jan2013.pdf",null,null,"N",null,"FT4"]
["prazosine","PhVWP recommendation",null,"March 2009","CMD website","Submission of variation 15 June 2009; approval of variation 15 October 2009","http://db.cbg-meb.nl/veegactie/nlvert/non-selective-alphablockers-and-PD5-inhibitor.pdf","A","October 2009","FT2"]
["Primidon","PhVWP recommendation",null,"February 2012","CMD website","2012-04-01","http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","A","February 2012","FT1"]
["Priorix","Art 30 referral","EMEA/H/A-30/1283","Mei 2012","EU commission website",null,"EU commission website","N",null,"FT4"]
["procarbazine HCl","Paediatric WS art 45",null,"Januari 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Allopurinol_Jul2012.pdf","N",null,"FT3"]
["prochloorperazine","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["propafenone","CSP"," UK/H/PSUR/0038/001","July 2011","http://db.cbg-meb.nl/veegactie/CSP/Propafenone-July2011.pdf",null,null,"N",null,"FT2"]
["propofol","Paediatric WS art 45"," DE/W/004/pdWs/001","March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Propofol-MArch2010.pdf","N",null,"FT1"]
["Propofol","CSP","NO/H/PSUR/0009/001","May 2011","http://db.cbg-meb.nl/veegactie/csp/propofol_May2011.pdf",null,null,"N",null,"FT1"]
["propranolol","Paediatric WS art 45",null,"February 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Propranolol-Febr2011.pdf","N",null,"FT2"]
["propylthiouracil ","PhVWP recommendation ",null,"January 2010","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h52115.pdf","A","February 2010","FT4"]
["pulmozyme","CSP",null,"August 2010","http://db.cbg-meb.nl/veegactie/csp/Pulmozyme-Aug2010.pdf",null,null,"N",null,"FT3"]
["quetiapine","CSP","NL/H/PSUR/0021/004","August 2012","http://db.cbg-meb.nl/veegactie/csp/Quetiapine_Aug2012.pdf",null,null,"N",null,"FT1"]
["quetiapine","PhVWP recommendation",null,"July 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antipsychotica_brief_registratiehouders.pdf","A",null,"FT1"]
["quetiapine ","Paediatric WS art 45",null,"June 2010",null,null,null,"N",null,"FT1"]
["quetiapine hemifumaraat/quetiapine","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["quinagolide","PhVWP recommendation ",null,"July 2012","CMD website","Nov 2012","http://db.cbg-meb.nl/veegactie/nlvert/Divers_PhVWP_risk_of_impils_control_disorders_Jul2012.pdf","A",null,"FT1"]
["quinapril","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["quinapril","Paediatric WS art 45",null,"March 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Quinapril-March2011.pdf","N",null,"FT2"]
["quinapril","CSP"," DK/H/PSUR/0013/002","December 2011","http://db.cbg-meb.nl/veegactie/CSP/quinapril-Dec2011.pdf",null,null,"N",null,"FT2"]
["quinapril-HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["quinapril-HCT","CSP",null,"December 2009","http://db.cbg-meb.nl/veegactie/csp/quinapril-hctz-Dec2009.pdf",null,null,"N",null,"FT2"]
["Rabeprazol","Class effects of proton-pump inhibitors on magnesium blood levels in long-term users",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/PPI_hypomagnesiemie_maart2012.pdf","A","April 2012","FT4"]
["rabeprazol","Others",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/Nlvert/PPI_botfractuur_maart2012.pdf","A","April 2012","FT4"]
["ramipril","Art 30 referral",null,"April 2009","EU commission website",null,"EU commission website","A","June 2009","FT2"]
["ramipril","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","A","June 2009","FT2"]
["ramipril","Paediatric WS art 45",null,"March 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Ramipril-Maart2011-rev.pdf","N",null,"FT2"]
["Ramipril Felodipine","CSP"," SE/H/PSUR/0038/001","February 2011","http://db.cbg-meb.nl/veegactie/CSP/Ramipril-Felodipine-Febr2011.pdf",null,null,"N",null,"FT2"]
["ramipril-HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","A",null,"FT2"]
["ramipril-HCT","Art 30 referral",null,"April 2009","EU commission website",null,"EU commission website","A",null,"FT2"]
["Ranitidine","CSP",null,"April 2010","http://db.cbg-meb.nl/veegactie/csp/Ranitidine.pdf",null,null,"N",null,"FT4"]
["Ranitidine","Paediatric WS art 45",null,"March 2008","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h14330.pdf","N",null,"FT4"]
["Ranitidine","CSP","IT/H/PSUR/0016/003","2014-06-05","http://db.cbg-meb.nl/veegactie/csp/Ranitidine_Jun2014.pdf",null,null,"N",null,"FT4"]
["reboxetine","CSP ","UK/H/PSUR/0053/001","January 2011","http://db.cbg-meb.nl/veegactie/csp/Reboxetine-methanesulphonate-Jan2011.pdf",null,null,"N",null,"FT1"]
["Reboxetine","CSP","UK/H/PSUR/0053/001","January 2011","http://db.cbg-meb.nl/veegactie/csp/REBOXETINE_Jan2012.pdf",null,null,"N",null,"FT1"]
["remifentanil","CSP",null,"August 2009","http://db.cbg-meb.nl/veegactie/csp/remifentanil-8-2009.pdf",null,null,"N",null,"FT1"]
["remifentanil","Paediatric WS art 45"," UK/W/0012/pdWS/001","September 2010","CMD website",null," http://db.cbg-meb.nl/veegactie/nlvert/Remifentanil-SEP2010.pdf","N",null,"FT1"]
["reviparine","CSP",null,"December 2009","http://db.cbg-meb.nl/veegactie/csp/reviparine-Dec2009.pdf",null,null,"N",null,"FT2"]
["ribavirine","CSP","NL/H/PSUR/0036/004","Augustus 2013","http://db.cbg-meb.nl/veegactie/csp/Ribavirin_Aug2014.pdf",null,null,"N",null,"FT4"]
["rimexolone ","CSP",null,"February 2010","http://db.cbg-meb.nl/veegactie/csp/rimexolone-2-2010.pdf",null,null,"N",null,"FT1"]
["Rimfampicin","Paediatric WS art 45"," DE/W/020/pdWS/001","February 2012",null,"CMD website","http://db.cbg-meb.nl/veegactie/nlvert/Rifampicine_feb2012.pdf","N",null,"FT4"]
["Risedronaat","CSP","SE/H/PSUR/0008/004","January 2012","http://db.cbg-meb.nl/veegactie/csp/Risedronaat_Jan2012.pdf",null,null,"N",null,"FT2"]
["risedronate","Paediatric WS art 45",null,"October 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/risedronaat-Oct2010.pdf","N",null,"FT2"]
["risedronate","CSP","SE/H/PSUR/008/002","October 2010","http://db.cbg-meb.nl/veegactie/csp/Risedronate-Oct2010.pdf",null,null,"N",null,"FT2"]
["risedronate","PhVWP recommendation ",null,"August 2012","CMD website","2012-08-01","http://db.cbg-meb.nl/veegactie/nlvert/Risedronate-August2012.pdf","A",null,"FT2"]
["risedronic acid","Art 30 referral",null,"July 2011","CMD website",null,"CMD website","A","August 2011","FT2"]
["risidronic acid","CSP",null,"January 2010","http://db.cbg-meb.nl/veegactie/csp/risedronaat-Jan2010.pdf",null,null,"N",null,"FT2"]
["risperidon","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009.pdf","A","December 2009","FT1"]
["risperidon","Art 30 referral",null,"October 2008","EU commission website",null,"EU commission website","A","December 2009","FT1"]
["risperidon","PhVWP recommendation",null,"July 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antipsychotica_brief_registratiehouders.pdf","A",null,"FT1"]
["risperidon","Art 45","IS/W/0001/pdWS/001","November 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Art45_Risperidone_Jan2013.pdf","N",null,"FT1"]
["risperidon","WS art 45","IS/W/0001/pdWS/001","Dec 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Art45_risperidon_Dec2012.pdf","N",null,"FT1"]
["risperidone","Paediatric WS art 45","IS/W/0001/pdWS/001","January 2013","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Risperidone_JAN2013.pdf","N",null,"FT1"]
["Risperidone","PSUR WS","BE/H/PSUR/0010/001","mei 2014","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/Risperidone_SAR_2014_04.pdf ",null,null,null,"mei 2014","FT1"]
["rizatriptan","CSP","NL/H/PSUR/0002/001","May 2011","http://db.cbg-meb.nl/veegactie/csp/rizatriptan-May2011.pdf",null,null,"N",null,"FT1"]
["rocuroniumbromide","CSP"," CZ/H/PSUR/0005/002","May 2012","http://db.cbg-meb.nl/veegactie/csp/Rocuronium_May2012.pdf",null,null,"N",null,"FT1"]
["Ropinirole","PhVWP recommendation ",null,"July 2012","CMD website","Nov 2012","http://db.cbg-meb.nl/veegactie/nlvert/Divers_PhVWP_risk_of_impils_control_disorders_Jul2012.pdf","A",null,"FT1"]
["ropinirole hydrochloride","Paediatric WS art 46"," FR/W/014/pdWS/001","November 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Ropinirole-hydrochloride-November2010.pdf","N",null,"FT1"]
["Ropivacaine","Paediatric WS art 45",null,"November 2011",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/Ropivacaine_Nov_2011.pdf","N",null,"FT1"]
["Ropivacaine","Paediatric WS art 45"," DE/W/0027/pdWS/001","Nov 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Ropivacaine_2012Feb.pdf","N",null,"FT1"]
["rosuvastatine","PhVWP recommendation",null,"October 2009","CMD website","Implementation until June 2010","http://db.cbg-meb.nl/veegactie/nlvert/statines-Oct2009.pdf","A","October 2009","FT2"]
["rosuvastatine","CSP",null,"May 2010","http://db.cbg-meb.nl/veegactie/csp/rosuvastatine-July2010.pdf",null,null,"N",null,"FT2"]
["rosuvastatine","CSP"," NL/H/PSUR/0019/004","July 2012","http://db.cbg-meb.nl/veegactie/CSP/Rosuvastatine-July2012.pdf",null,null,"N",null,"FT2"]
["rosuvastatine","PhVWP recommendation",null,"February 2012","CMD website","Implementation until May 2012","http://db.cbg-meb.nl/veegactie/nlvert/Statine-March2012.pdf","A","March 2012","FT2"]
["rosuvastatine","PhVWP recommendation",null,"February 2012","CMD website","Implementation until May 2012","http://db.cbg-meb.nl/veegactie/nlvert/Rosuvastatine-March2012.pdf","A","March 2012","FT2"]
["Rosuvastatine","CSP","NL/H/PSUR/0019/005","July 2013","http://db.cbg-meb.nl/veegactie/csp/Rosuvastatine_Jul2013.pdf",null,null,"N",null,"FT2"]
["Rotigotine","PhVWP recommendation ",null,"July 2012","CMD website","Nov 2012","http://db.cbg-meb.nl/veegactie/nlvert/Divers_PhVWP_risk_of_impils_control_disorders_Jul2012.pdf","A",null,"FT1"]
["Roxithromycin","CSP","IT/H/PSUR/0008/001","November 2012"," http://db.cbg-meb.nl/veegactie/csp/Roxithromycin_Nov2012.pdf",null,null,"N",null,"FT4"]
["roxithromycine","PRAC Signal","hearing disorders","Feb 2013","EMA website","60 days",null,"A","Oct 2013","FT4"]
["roxithromycine","PRAC Signal","rhabdomyolyse","Feb 2013","EMA website","60 days",null,"A","Oct 2013","FT4"]
["Rupatadine","PSUR WS","ES/H/PSUR/0009/006","8 december 2014","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Pharmacovigilance_Legislation/PSUR/Summary_AR/rupatadine.pdf",null,null,"N"]
["Salbutamol","Paediatric WS art 45"," RO/W/0001/pdWS/001","april 2012","CMD website",null,null,"N",null,"FT3"]
["Salmeterol","CSP","UK/H/PSUR/0025/002","December 2011","http://db.cbg-meb.nl/veegactie/csp/Salmeterol_Dec2011.pdf",null,null,"N",null,"FT3"]
["Salmeterol/Fluticasonepropionaat","Paediatric WS art 45","DE/W/047/pdWS/001","Aug 2013",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/SalmeterolFluticason_aug2013.pdf","N",null,"FT3"]
["Salmeterol/Fluticasonepropionaat","Paediatric WS art 46","SE/W/005/pdWS/002 ","15 May 2013",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/SalmeterolFluticason_may2013.pdf",null,null,"FT3"]
["SeHCAT 370 kBq ","CSP",null,"September 2010","http://db.cbg-meb.nl/veegactie/csp/SeHCAT-Sept2010.pdf",null,null,"N",null,"FT2"]
["selegiline","CSP",null,"October 2010","http://db.cbg-meb.nl/veegactie/csp/selegiline-Oct2010.pdf",{"$nulls":4},"FT1"]
["Selegiline","CSP","CZ/H/PSUR/0022/002","May 2013","http://db.cbg-meb.nl/veegactie/csp/Selegiline_May2013.pdf",null,null,"N",null,"FT1"]
["sertindol","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["Sertraline","CSP","NL/H/PSUR/0059/001","October 2012","http://db.cbg-meb.nl/veegactie/csp/Sertraline_Oct2012.pdf",null,null,"N",null,"FT4"]
["sertraline","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["sertraline","Art 31 referral ",null,"August 2005","EU commission website",null,"EU commission website","A",null,"FT1"]
["sertraline","Art 30 referral",null,"March 2009","EU commission website",null,"EU commission website","N",null,"FT1"]
["Sertraline","PhVWP recommendation",null,"March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/SSRIs-muv-Fluoxetine-5-2010.pdf","A","June 2010","FT1"]
["Sertraline","PhVWP recommendation ",null,"March 2012","CMD website","August 2012","http://db.cbg-meb.nl/veegactie/nlvert/SSRIs_increased_ risk_ of_male_infertilityMar2012.pdf","A",null,"FT1"]
["Sevoflurane","CSP"," IE/H/PSUR/0006/003","August 2011","http://db.cbg-eb.nl/veegactie/csp/Sevoflurane_Aug_2011.pdf",null,null,"N",null,"FT1"]
["Sevoflurane","CSP","IE/H/PSUR/0006/002","September 2011","http://db.cbg-meb.nl/veegactie/csp/sevoflurane_Sep2011.pdf",null,null,"N",null,"FT1"]
["Simvastatin","PRAC recommendation",null,"April 2014","http://db.cbg-meb.nl/veegactie/csp/Simvastatin_april2014.pdf",null,null,"N",null,"FT2"]
["simvastatine","PhVWP recommendation",null,"October 2009","CMD website","Implementation until June 2010","http://db.cbg-meb.nl/veegactie/nlvert/statines-Oct2009.pdf","A","February 2010","FT2"]
["simvastatine","Paediatric WS art 45",null,"May 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Simvastatine.pdf","A","February 2010","FT2"]
["simvastatine","CSP",null,"October 2009","http://db.cbg-meb.nl/veegactie/csp/Simvastatin-Sept09.pdf",null,null,"A","February 2010","FT2"]
["simvastatine","CSP"," IE/H/PSUR/0009/002","February 2012","http://db.cbg-meb.nl/veegactie/CSP/simvastatineFebruary2012.pdf",null,null,"N",null,"FT2"]
["Sodium Iodide","CSP ",null,"November 2010","http://db.cbg-meb.nl/veegactie/csp/Sodium-iodide-nov2010.pdf",null,null,"N",null,"FT2"]
["Somatropin","CSP ",null,"February 2010","http://db.cbg-meb.nl/veegactie/csp/Somatropin-feb2010.pdf",null,null,"N",null,"FT4"]
["Spiriva","CSP ","NL/H/PSUR/0017/001","December 2010","http://db.cbg-meb.nl/veegactie/csp/Spiriva-dec2010.pdf",null,null,"N",null,"FT3"]
["Sucralfaat","Paediatric WS art 45"," AT/W/0008/pdWS/001","July 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Sucralfaat-Jul2012.pdf","N",null,"FT4"]
["sufentanil","CSP"," PT/H/PSUR/0010/001","November 2010","http://db.cbg-meb.nl/veegactie/csp/Sufentanil-Nov2010.pdf",{"$nulls":4},"FT1"]
["Sufentanil","CSP","PT/H/PSUR/0010/002","April 2014","http://db.cbg-meb.nl/veegactie/csp/Sufentanilapr2014.pdf",null,null,"N",null,"FT1"]
["Sufentanil citrate","Paediatric WS art 45"," DE/W/0028/pdWS/001","June 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Sufentanil_Art45_June2012.pdf","N",null,"FT1"]
["Sulbactam","CSP","AT/H/PSUR/0004/002","September 2011","http://db.cbg-meb.nl/veegactie/csp/Sulbactam_Nov2011.pdf",null,null,"N",null,"FT4"]
["sulfamethoxazol","PhVWP recommendation",null,"October 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","N","February 2012","FT1"]
["sulproston","CSP"," FR/H/PSUR/0038/001","September 2011","http://db.cbg-meb.nl/veegactie/CSP/sulprostonSeptember2011.pdf",null,null,"N",null,"FT2"]
["Sumatriptan","CSP + PDWS","NL/H/PSUR/0016/002 & NL/H/pdWS/0012/002","October 2012","http://db.cbg-meb.nl/veegactie/csp/Art45_Sumatriptan_Dec2009.pdf   ","http://db.cbg-meb.nl/veegactie/csp/Art46_Sumatriptan_Oct2012.pdf",null,"N",null,"FT1"]
["Sumatriptan","CSP"," NL/H/PSUR/0016/002","October 2012","http://db.cbg-meb.nl/veegactie/csp/CSP_Sumatriptan_Oct2012.pdf",null,null,"N",null,"FT1"]
["Sumatriptan ","Paediatric WS art 45","NL/W/0012/pdWS/001  ","December 2009",null,null,null,"N",null,"FT1"]
["Tacrolimus","CSP","IE/H/PSUR/0012/005","November 2012","http://db.cbg-meb.nl/veegactie/csp/Tacrolimus_nov2012.pdf",null,null,"N",null,"FT3"]
["Tamoxifen","Lareb Publication",null,"August 2009",null,null,null,"A","August 2009","FT3"]
["Tamoxifen","PhVWP recommendation",null,"October 2010","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Product_Information/PhVWP_Recommendations/Tamoxifen/Tamoxifen_and_the_risk_of_variability_in_clinical_response-_Rev0-_October_2010.pdf",null,"http://db.cbg-meb.nl/veegactie/nlvert/tamoxifen-Oct2010.pdf","A","November 2010","FT3"]
["Tamsulosine","CSP",null,"March 2010","http://db.cbg-meb.nl/veegactie/csp/Tamsulosine.pdf",null,null,"N",null,"FT4"]
["Tamsulosine","Paediatric WS art 45"," UK/W/039/pdWS/001","June 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Tamsulosine-Jun2012.pdf","N",null,"FT4"]
["Tamsulosine","CSP","NL/H/PSUR/0014/002","November2012","http://db.cbg-meb.nl/veegactie/csp/",null,null,"N",null,"FT4"]
["tamsulosine","PRAC Signal",null,"July 2013","EMA website","60 days",null,"A","Oct 2013","FT4"]
["Technetium (99m Tc) macrosalb","CSP"," DK/H/PSUR/0048/001","June 2011",null,null,"http://db.cbg-meb.nl/veegactie/CSP/techneticum(99mTc)macrosalb-june2011.pdf","N",null,"FT2"]
["Technetium (99mTc) exametazime ","CSP ",null,"December 2010","http://db.cbg-meb.nl/veegactie/csp/Technetium-exametazime-December2010.pdf",null,null,"N",null,"FT2"]
["Technetium-99m","CSP",null,"December 2009","http://db.cbg-meb.nl/veegactie/csp/Technetium99m-Dec2009.pdf",null,null,"N",null,"FT2"]
["Teicoplanine","CSP",null,"July 2009","http://db.cbg-meb.nl/veegactie/csp/Teicoplanin.pdf",null,null,"N",null,"FT4"]
["Teicoplanine","Art. 30 referral","EMEA/H/A-30/1301","September 2013","EU commission website",null,null,"N",null,"FT4"]
["Telmisartan","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["Telmisartan-HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["Teniposide","CSP ","AT/H/PSUR/0025/001","November 2010","http://db.cbg-meb.nl/veegactie/csp/Teniposide-Nov2010.pdf",null,null,"N",null,"FT3"]
["Tenoxicam","PhVWP recommendation",null,"October 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antiepileptica_bone_disorders_February_2012.pdf","N","February 2012","FT1"]
["Terazosine","PhVWP recommendation",null,"March 2009","CMD website","Submission of variation 15 June 2009; approval of variation 15 October 2009","http://db.cbg-meb.nl/veegactie/nlvert/non-selective-alphablockers-and-PD5-inhibitor.pdf","A","October 2009","FT2"]
["Terbinafine","CSP"," SK/H/PSUR/0005/001","June 2010","http://db.cbg-meb.nl/veegactie/csp/Terbinafine_jun_2012.pdf",null,null,"N",null,"FT4"]
["Terlipressin","CSP","DK/H/PSUR/0034/002","Augustus 2013","http://db.cbg-meb.nl/veegactie/csp/Terlipressin_Aug2013.pdf",null,null,"N",null,"FT4"]
["Testosteron","Paediatric WS art 45","NL/W/0026/pdWS/001","April 2013","CMD website","x","http://db.cbg-meb.nl/veegactie/nlvert/Testosterone_Apr2013.pdf","N",null,"FT4"]
["Testosteron","Art. 31 referral","EMEA/H/A-1383","december 2014"," http://db.cbg-meb.nl/veegactie/csp/Art31_Testosteron_Nov14.pdf",null,"http://ec.europa.eu/health/documents/community-register/html/ho25421.htm","N","december 2014","FT4"]
["Testosteron","Art. 31 referral","EMEA/H/A-31/1396","21 november 2014","http://db.cbg-meb.nl/veegactie/nlvert/Testosteron_Nov14.pdf",null,"http://ec.europa.eu/health/documents/community-register/html/ho25421.htm","N",null,"FT4"]
["tetrabenazine","CSP",null,"August 2009","http://db.cbg-meb.nl/veegactie/csp/tetrabenazine-8-2009.pdf",null,null,"N",null,"FT1"]
["Theophylline","Paediatric WS art 45","DK/W/0021/pdWS/001","August 2013","http://db.cbg-meb.nl/veegactie/csp/Theophylline_aug2014.pdf",null,null,"N",null,"FT3"]
["Thiamazole","CSP","PL/H/PSUR/0021","June 2011","http://db.cbg-meb.nl/veegactie/csp/Thiamazole-jun2011.pdf",null,null,"N",null,"FT4"]
["Thiamozole","Paediatric WS art 45"," DK/W/010/pdWS/001","November 2011","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h02224.pdf","N",null,"FT4"]
["Thiopental","PRAC signal",null,"December 2013","EMA website",null,null,"N",null,"FT1"]
["Thymoglobuline","CSP"," EE/H/PSUR/0008/001","september 2011","http://db.cbg-meb.nl/veegactie/csp/Thymoglobuline_Sep2011.pdf",null,null,"N",null,"FT3"]
["Thymoglobuline","Paediatric WS art 45","DE/W/0011/pdWS/001","18 september 2014","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Paediatric_Regulation/Assessment_Reports/Article_45_work-sharing/Thymoglobuline_Art_45_PAR_2014_12.pdf"]
["tiapride","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["tiapride                  ","CSP ",null,"November 2010","http://db.cbg-meb.nl/veegactie/csp/Tiapride-November2010.pdf",null,null,"N",null,"FT1"]
["tiapridehydrochloride","PhVWP recommendation",null,"July 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Antipsychotica_brief_registratiehouders.pdf","A",null,"FT1"]
["tibolone","PhVWP recommendation",null,"December 2011","CMD website","Implementation until April 2012","http://db.cbg-meb.nl/veegactie/nlvert/Tibolone-dec2011.pdf","A","February 2012","FT2"]
["tiludronic acid","Art 30 referral",null,"July 2011","EU commission website",null,"EU commission website","A","August 2011","FT2"]
["tiludroninic acid","CSP","FR/H/PSUR/0048/002","Aug 2013","http://db.cbg-meb.nl/veegactie/csp/tiludronic acid-Aug 2013.pdf",null,null,"N",null,"FT2"]
["Timolol","Paediatric WS art 45"," AT/W/0005/pdWS/001","June 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/timolol-June2011-Art45.pdf","N",null,"FT1"]
["Timolol","PhVWP recommendation",null,"January 2012","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Beta_blocking_agents_January2012.pdf","N",null,"FT1"]
["Timolol ","CSP","DE/H/PSUR/0012/002","October 2012","http://db.cbg-meb.nl/veegactie/csp/Timolol_Oct2012.pdf",null,null,"N",null,"FT1"]
["tiotropium bromide","PRAC Signal",null,"June 2013","EMA website","60 days",null,"A","Oct 2013","FT3"]
["tizanidine","CSP","FI/H/PSUR/0020/001","September 2010","http://db.cbg-meb.nl/veegactie/csp/tizanidine-Sep2010.pdf",{"$nulls":4},"FT1"]
["tobramycin","Paediatric WS art 45"," FI/W/002/pdWS/001","August 2012","http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Paediatric_Regulation/Assessment_Reports/Article_45_work-sharing/Tobramycin-PartII_-_Art.45_PublicAR.pdf",{"$nulls":4},"FT4"]
["Tobramycin","Paedatric WS art 45","FI/W/002/pdWS/001","October 2012","CMD website","x","http://db.cbg-meb.nl/veegactie/nlvert/Tobramycin_Okt2012.pdf","N",null,"FT4"]
["Tobramycine","CSP"," UK/H/PSUR/0029/001","August 2010","http://db.cbg-meb.nl/veegactie/csp/Tobramycin-aug 2010.pdf",null,null,"N",null,"FT4"]
["Tolcapone","PhVWP recommendation ",null,"July 2012","CMD website","Nov 2012","http://db.cbg-meb.nl/veegactie/nlvert/Divers_PhVWP_risk_of_impils_control_disorders_Jul2012.pdf","A",null,"FT1"]
["Tolterodine","CSP"," SE/H/PSUR/0003/002","February 2011","http://db.cbg-meb.nl/veegactie/csp/Tolterodinde-aug_2010.zip",null,null,"N",null,"FT4"]
["Tolterodine","Paediatric WS art 45",null,"2006-09-01","CMD website",null,"http://db.cbg-meb.nl/IB-teksten/h22148.pdf",null,null,"FT4"]
["Tolterodine","PSUR WS","SE/H/PSUR/0003/003","juli 2014","http://db.cbg-meb.nl/veegactie/csp/Tolterodine_oktober2014.pdf",null,null,null,"22 januari 2015","FT4"]
["topiramaat","PhVWP recommendation",null,"July 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/anti-epileptics-and-suicidal-behaviour-lamotrigine-2008.pdf","A","July 2008","FT1"]
["topiramaat","Art 30 referral",null,"October 2009","EU commission website",null,"EU commission website","N",null,"FT1"]
["topiramaat","CSP","SE/H/PSUR/0018/002","December 2012","http://db.cbg-meb.nl/veegactie/csp/Topiramate_DEC2012.pdf",null,null,"N",null,"FT1"]
["topiramaat","Paediatric WS art 45"," MT/W/0002/pdWS/001","2010-11-01","CMDh website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Topiramate-Nov2010.pdf","N",null,"FT1"]
["Topiramaat","PhVWP recommendation",null,"January 2012","CMD website","June 2012","http://db.cbg-meb.nl/veegactie/nlvert/Topiramaat_February_2012.pdf","A",null,"FT1"]
["Tramadol","PhVWP recommendation",null,"July 2012","CMD website","2012-11-01","http://db.cbg-meb.nl/veegactie/nlvert/Tramadol_Jul2012.pdf","A",null,"FT1"]
["Tramadol","PRAC Signal",null,"June 2013","EMA website","60 days",null,"A","Oct 2013","FT1"]
["Tramadol","PRAC signal",null,"June 2013","EMA website",null,null,"N",null,"FT1"]
["Tramadol hydrochloride + paracetamol","CSP","FR/H/PSUR/0054/001","November 2012","http://db.cbg-meb.nl/veegactie/csp/",null,null,"N",null,"FT1"]
["trandolapril","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["trandolapril-HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","N",null,"FT2"]
["tranexamic acid","Paediatric WS art 45",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Tranexamic-acid-Oct2009.pdf","N",null,"FT2"]
["trazodon","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["Trazodone","CSP"," LT/H/PSUR/0003/002","May 2012","http://db.cbg-eb.nl/veegactie/csp/Trazodone_May_2012.pdf",null,null,"N",null,"FT1"]
["Trazodone","CSP",null,"March 2010","http://db.cbg-meb.nl/veegactie/csp/trazodone-3-2010.pdf",null,null,"N",null,"FT1"]
["Trazodone","Art 45","UK/W/060/pdWS/001","March 2013","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Art45_trazodone_March2013.pdf","N",null,"FT1"]
["Trazodone","PRAC Signal",null,"May 2013","EMA website","90 days",null,"A","Oct 2013","FT1"]
["Trazodone","PRAC signal",null,"May 2013","EMA website",null,null,"N",null,"FT1"]
["Triamcinolon","PRAC signal",null,"January 2014","EMA website",null,null,"N",null,"FT4"]
["Triazolam","CSP","FI/H/PSUR/0016/002","januari 2014","http://db.cbg-meb.nl/veegactie/csp/Triazolam_jan2014.pdf",null,null,"N",null,"FT1"]
["Trimegestone+EE","CSP",null,"October 2010","http://db.cbg-meb.nl/veegactie/csp/trimegestone-EE-Oct2010.pdf",null,null,"N",null,"FT2"]
["triptorelin","CSP ",null,"March 2010","http://db.cbg-meb.nl/veegactie/csp/Triptorelin-March2010.pdf",null,null,"N",null,"FT2"]
["triptorelin","Paediatric WS art 45",null,"October 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Triptorelin-Oct2010.pdf","N",null,"FT2"]
["triptorelin","PhVWP recommendation",null,"March 2012","CMD website","Implementation until July 2012","http://db.cbg-meb.nl/veegactie/nlvert/GnRH-March2012.pdf","A","April 2012","FT2"]
["Tropisetron","CSP ","FR/H/PSUR/0047/001","December 2010","http://db.cbg-meb.nl/veegactie/csp/Tropisetron-dec2010.pdf",null,null,"N",null,"FT3"]
["Ursodeoxycholzuur","CSP",null,"September 2009","http://db.cbg-meb.nl/veegactie/csp/Urdodeoxcycholic.pdf",null,null,"N",null,"FT4"]
["ursodeoxycholzuur","CSP","MT/H/PSUR/0001/002","18 december 2012","http://db.cbg-meb.nl/veegactie/csp/Ursodeoxycholzuur_december_2012.pdf",null,null,"N",null,"FT4"]
["Ursodeoxycholzuur ","Paediatric WS art 45","UK/W/036/pdWS/001","Juli 2013",null,null,null,"N",null,"FT4"]
["Valaciclovir","Art 30 referral",null,"Juli 2010","CMD website",{"$nulls":4},"FT4"]
["Valaciclovir","CSP ",null,"November 2010","http://db.cbg-meb.nl/veegactie/csp/Valaciclovir-nov2010.rtf",null,null,"N",null,"FT4"]
["Valganciclovir","CSP"," NL/H/PSUR/0024/001 ","March 2012","http://db.cbg-meb.nl/veegactie/csp/Valganciclovir_mrt_2012.pdf",null,null,"N",null,"FT4"]
["Valproate","Art. 31 referral","EMEA/H/A-31/1387","november 2014","http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Valproate_and_related_substances/human_referral_prac_000032.jsp&mid=WC0b01ac05805c516f",null,null,null,"november 2014","FT1"]
["valsartan","Art 30 referral",null,"March 2009","CMD website",null,"CMD website","A","June 2009","FT2"]
["valsartan","CSP"," SE/H/PSUR/0024/002","March 2012","http://db.cbg-meb.nl/veegactie/csp/valsartan-March2012.pdf",null,null,"N",null,"FT2"]
["valsartan","PhVWP recommendation",null,"December 2008","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","A","June 2009","FT2"]
["Valsartan","CSP","SE/H/PSUR/0024/003","February 2013","http://db.cbg-meb.nl/veegactie/csp/Valsartan_Feb2013.pdf",null,null,"N",null,"FT2"]
["valsartan-HCT","PhVWP recommendation",null,"July 2011","CMD website","Publication; no implementation plan","http://db.cbg-meb.nl/veegactie/nlvert/ACE-AIIRA-HCTZ-July2011.pdf","A",null,"FT2"]
["valsartan-HCT","Art 30 referral",null,"June 2009","EU commission website",null,"EU commission website","A",null,"FT2"]
["valsartan-HCT","CSP"," SE/H/PSUR/0013/002","March 2012","http://db.cbg-meb.nl/veegactie/csp/Valsartan+HCT-Nov2011.pdf",null,null,"N",null,"FT2"]
["Vecuronium bromide","CSP","CZ/H/PSUR/0002/002","August 2011","http://db.cbg-meb.nl/veegactie/csp/vecuronium bromide_August2011.pdf",null,null,"N",null,"FT1"]
["venlafaxine","PhVWP recommendation",null,"January 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/suicidality-antidepressiva-1-2008.pdf","A","January 2008","FT1"]
["venlafaxine","Art 31 referral ",null,"August 2005","EU commission website",null,"EU commission website","A",null,"FT1"]
["venlafaxine","Art 30 referral",null,"November 2008","EU commission website",null,"EU commission website","N",null,"FT1"]
["venlafaxine","PhVWP recommendation",null,"March 2010","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/SNRI-s-5-2010.pdf","A","June 2010","FT1"]
["Venlafaxine","CSP"," ES/H/PSUR/0017/001","September 2010","http://db.cbg-eb.nl/veegactie/csp/Venlafaxine_Sep_2010.pdf",null,null,"N",null,"FT1"]
["verapamil","Paediatric WS art 45",null,"April 2011","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/Verapamil-April2011.pdf","N",null,"FT2"]
["vigabatrine","PhVWP recommendation",null,"July 2008","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/anti-epileptics-and-suicidal-behaviour-lamotrigine-2008.pdf","A","July 2008","FT1"]
["vigabatrine","PhVWP recommendation ",null,"October 2009","CMD website",null,null,"A",null,"FT1"]
["vigabatrine","CSP",null,"November 2009","http://db.cbg-meb.nl/veegactie/csp/vigabatrin-11-2009.pdf",null,null,"N",null,"FT1"]
["Vinorelbine","Paediatric WS art 45","NL/W/0018/pdWS/001","12 April 2011",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/Vinorelbine_apr2011.pdf","N",null,"FT3"]
["Vinorelbine/Navelbine","CSP","CZ/H/PSUR/009/002","July 2013","http://db.cbg-meb.nl/veegactie/csp/Vinorelbine_Jul2013.pdf",null,null,"N",null,"FT3"]
["Voluven","Paediatric WS art 46","DE/W/048/pdWS/001 ","Oktober 2012","http://db.cbg-meb.nl/veegactie/csp/Voluven-Oktober2012.pdf",null,null,"N",null,"FT4"]
["xalatan","CSP",null,"October 2010","http://db.cbg-meb.nl/veegactie/csp/xalatan-Oct2010.pdf",{"$nulls":4},"FT1"]
["Zanamivir","CSP ","SE/H/PSUR/0017/002","October 2010","http://db.cbg-meb.nl/veegactie/csp/Zanamivir-oct2010.pdf",null,null,"N",null,"FT4"]
["zanamivir","PSUR WS","SE/H/PSUR/0017/004","December 2012",null,null,"http://db.cbg-meb.nl/veegactie/nlvert/Zanamivir_december2012.pdf","N",null,"FT4"]
["Zidovudine ","CSP"," UK/H/PSUR/0035/001 ","May 2011","http://db.cbg-meb.nl/veegactie/csp/Zidovudine-may_2011.pdf",null,null,"N",null,"FT4"]
["ziprasidone","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]
["ziprasidone","CSP"," SE/H/PSUR/0030/003","March 2011","http://db.cbg-meb.nl/veegactie/csp/ziprasidone-Mar2011.pdf",{"$nulls":4},"FT1"]
["zoledronic acid","Art 20 referral",null,"July 2011",null,null,"CMD website","A","August 2011","FT2"]
["Zoledronic acid","innovator","EMEA/H/C/336/II/45","October 2013","EU commission website",null,"EU commission website","A",null,"FT3"]
["zolmitriptan","CSP",null,"January 2010","http://db.cbg-meb.nl/veegactie/csp/zolmitriptan-1-2010.pdf",null,null,"N",null,"FT1"]
["zomacton","CSP","FR/H/PSUR/0006/001","February 2010","http://db.cbg-meb.nl/veegactie/CSP/Zomacton_Feb2010.pdf",null,null,"N",null,"FT4"]
["Zotepine","CSP","CZ/H/PSUR/0025/001","December 2011","http://db.cbg-meb.nl/veegactie/csp/zotepine_dec2011.pdf",null,null,"N",null,"FT1"]
["zuclopentixol decanoaat/zuclopentixol dihydrochloride/zuclopentixol acetaat","PhVWP recommendation ",null,"October 2009","CMD website",null,"http://db.cbg-meb.nl/veegactie/nlvert/VTE-mortality-10-2009 .pdf","A","December 2009","FT1"]

{"sheet":"Blad2","index":1,"n_rows":0,"n_cols":0,"rows_kept":0,"cut":false,"hidden":false,"merged":[],"flags":["formulas_cached_only"]}

{"sheet":"Blad3","index":2,"n_rows":0,"n_cols":0,"rows_kept":0,"cut":false,"hidden":false,"merged":[],"flags":["formulas_cached_only"]}